data_1jbf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1jbf _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 69.8 ttt-85 . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 58.4 m -126.62 153.37 45.42 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.711 0.804 . . . . 0.0 110.424 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.5 p -139.52 143.79 37.6 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.256 1.423 . . . . 0.0 108.932 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.81 109.48 2.49 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -104.02 179.03 24.95 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.223 0.916 . . . . 0.0 111.106 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.81 -44.28 46.48 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.865 3.043 . . . . 0.0 112.023 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -99.47 48.38 0.95 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.53 1.132 . . . . 0.0 109.564 -176.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.53 -168.4 52.72 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -67.67 118.54 11.08 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.792 0.437 . . . . 0.0 110.652 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.3 m -99.73 147.62 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.5 m -128.98 144.45 51.19 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.694 0.798 . . . . 0.0 111.153 -173.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 C--O 1.251 1.172 0 C-N-CA 125.206 1.402 . . . . 0.0 109.479 177.333 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 . . . . . 0 CA--C 1.527 0.086 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.9 m -140.03 159.68 41.64 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 123.729 0.812 . . . . 0.0 109.619 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.5 p -134.41 142.08 47.03 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.78 1.232 . . . . 0.0 109.024 -175.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -71.15 108.58 4.73 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -108.01 -179.06 22.08 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.413 1.006 . . . . 0.0 111.274 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.25 -43.42 56.23 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 124.056 3.17 . . . . 0.0 112.278 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.4 m-90 -99.44 47.05 0.96 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.451 1.1 . . . . 0.0 109.733 -175.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.44 -163.48 48.53 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -69.26 114.18 7.28 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.77 0.428 . . . . 0.0 110.407 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.1 m -99.59 127.49 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.0 m -99.87 152.23 20.39 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.404 0.681 . . . . 0.0 111.844 -170.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 C--O 1.249 1.063 0 C-N-CA 126.16 1.784 . . . . 0.0 109.306 -176.403 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 . . . . . 0 CA--C 1.529 0.137 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 39.0 m -140.2 156.17 46.62 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 170.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -149.11 150.79 33.3 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.134 0.974 . . . . 0.0 109.712 -177.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -66.68 110.3 3.17 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.55 176.75 24.38 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.41 -43.37 58.98 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.814 3.009 . . . . 0.0 111.983 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -99.51 47.82 0.95 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.618 1.167 . . . . 0.0 109.718 -176.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.74 -170.86 54.36 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 49.6 m95 -65.76 112.46 3.73 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.116 0.566 . . . . 0.0 110.808 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.8 p -100.16 137.59 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.828 1.251 . . . . 0.0 108.382 176.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.0 m -105.23 150.79 24.81 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.823 0.849 . . . . 0.0 110.112 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 20.5 ptt? . . . . . 0 C--O 1.251 1.155 0 C-N-CA 125.531 1.533 . . . . 0.0 110.709 -169.509 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.3 m -139.53 163.15 33.31 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.638 0.775 . . . . 0.0 110.219 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.4 t -148.1 152.99 38.27 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.151 0.98 . . . . 0.0 109.619 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -76.88 94.02 3.84 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.658 0.783 . . . . 0.0 108.894 176.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.94 176.04 54.79 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.94 -43.24 61.29 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.993 3.128 . . . . 0.0 112.193 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -99.46 47.06 0.96 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.579 1.152 . . . . 0.0 109.565 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.78 -172.38 54.87 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -64.86 139.24 58.74 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.953 0.501 . . . . 0.0 111.843 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.1 p -139.29 141.05 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 125.377 1.471 . . . . 0.0 108.038 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.8 m -111.79 145.75 38.85 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.421 1.088 . . . . 0.0 110.26 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 28.5 ttt . . . . . 0 C--O 1.25 1.109 0 CA-C-O 117.678 -1.154 . . . . 0.0 110.502 -177.397 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? . . . . . 0 CA--C 1.529 0.137 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -140.36 161.56 37.4 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 123.683 0.793 . . . . 0.0 109.985 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.5 t -147.88 152.21 37.2 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.448 1.099 . . . . 0.0 109.18 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -69.43 108.42 3.74 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 176.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.28 175.76 29.76 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.34 -44.52 45.45 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.766 2.978 . . . . 0.0 111.836 176.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.7 m-90 -99.59 49.6 0.93 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.551 1.14 . . . . 0.0 109.552 -176.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.8 -171.6 54.61 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -65.67 116.03 6.46 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.205 0.602 . . . . 0.0 110.999 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.1 p -99.94 138.98 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 124.849 1.26 . . . . 0.0 108.115 175.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.9 m -115.08 145.35 42.42 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.0 0.92 . . . . 0.0 110.513 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 C--O 1.251 1.142 0 CA-C-O 117.308 -1.33 . . . . 0.0 109.33 -178.736 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 81.6 m -140.03 149.09 42.76 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 123.53 0.732 . . . . 0.0 109.964 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.3 t -150.08 150.63 31.99 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.259 1.024 . . . . 0.0 109.704 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -69.43 109.31 4.14 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -101.86 178.78 27.35 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.031 0.824 . . . . 0.0 111.055 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -56.89 -44.32 45.93 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.863 3.042 . . . . 0.0 111.957 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.4 m-90 -99.46 49.09 0.94 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.545 1.138 . . . . 0.0 109.573 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.57 -168.17 52.46 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -176.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 56.0 m95 -67.76 116.2 8.18 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.934 0.493 . . . . 0.0 110.73 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.8 m -99.95 156.17 4.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 124.702 1.201 . . . . 0.0 108.138 173.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.1 m -136.23 145.71 45.95 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.099 0.56 . . . . 0.0 110.983 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 94.2 mmm . . . . . 0 C--O 1.251 1.167 0 C-N-CA 126.405 1.882 . . . . 0.0 109.946 -178.75 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.5 mtm-85 . . . . . 0 C--O 1.232 0.142 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 19.9 m -134.96 157.82 45.92 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.986 0.915 . . . . 0.0 109.779 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 73.6 p -134.12 134.73 42.58 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.662 1.185 . . . . 0.0 109.271 -172.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -78.45 78.29 4.92 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.48 0.712 . . . . 0.0 109.197 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.38 -169.33 45.43 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.276 0.941 . . . . 0.0 111.601 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -51.01 -38.67 59.64 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 124.67 3.58 . . . . 0.0 113.048 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -99.59 32.02 2.97 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.426 1.091 . . . . 0.0 110.853 -177.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.54 -157.24 41.94 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -66.5 94.3 0.27 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.934 0.894 . . . . 0.0 110.781 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.4 m -99.57 131.94 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.2 m -99.44 144.34 28.66 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.226 0.61 . . . . 0.0 111.177 -169.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 58.0 mmm . . . . . 0 C--O 1.249 1.073 0 CA-C-O 116.763 -1.589 . . . . 0.0 110.879 -170.924 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 24.9 m -134.73 162.53 32.09 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.392 1.077 . . . . 0.0 109.343 175.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.2 p -137.82 142.58 40.79 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.996 1.318 . . . . 0.0 108.733 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -74.55 95.64 2.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.269 0.628 . . . . 0.0 109.355 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.84 178.04 53.98 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.697 0.665 . . . . 0.0 111.459 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.99 -41.85 9.24 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 124.003 3.135 . . . . 0.0 110.91 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -99.44 54.19 0.96 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.94 0.896 . . . . 0.0 109.018 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.76 -176.49 54.67 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 123.716 0.674 . . . . 0.0 111.723 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -65.54 140.02 58.52 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.459 0.704 . . . . 0.0 111.493 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -128.21 136.56 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 125.356 1.462 . . . . 0.0 107.625 174.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.8 m -110.34 148.48 31.88 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.141 0.976 . . . . 0.0 111.099 -174.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.4 mtm . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.443 1.497 . . . . 0.0 110.445 -177.789 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.2 mmm-85 . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 23.9 m -135.38 154.06 51.61 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.404 1.081 . . . . 0.0 108.795 173.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t -144.34 147.44 33.46 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.714 0.806 . . . . 0.0 109.945 -173.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -72.44 117.6 14.32 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.08 -167.77 11.12 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.522 1.058 . . . . 0.0 111.2 -176.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -51.04 -40.0 59.63 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.729 3.62 . . . . 0.0 113.739 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 -99.56 34.24 2.28 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.23 1.012 . . . . 0.0 110.697 -175.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.33 -156.79 41.79 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -65.98 97.46 0.36 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.995 0.518 . . . . 0.0 109.646 170.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.51 136.14 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.961 1.304 . . . . 0.0 108.17 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.2 m -99.73 146.38 26.6 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.659 0.784 . . . . 0.0 111.008 -174.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.6 mtt . . . . . 0 C--O 1.251 1.169 0 CA-C-O 117.513 -1.232 . . . . 0.0 110.283 -174.446 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.697 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 86.8 mmt-85 . . . . . 0 N--CA 1.456 -0.153 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 68.6 m -99.32 138.12 36.86 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.844 0.858 . . . . 0.0 111.173 -169.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.2 p -137.27 132.06 33.21 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.536 1.534 . . . . 0.0 108.536 -175.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.04 79.78 2.89 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.573 0.749 . . . . 0.0 109.504 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.39 -166.74 42.15 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.542 1.067 . . . . 0.0 111.44 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.68 -38.0 54.92 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 124.803 3.669 . . . . 0.0 113.28 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -99.55 28.32 4.71 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.414 1.086 . . . . 0.0 110.965 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.48 -156.27 40.81 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -66.01 90.13 0.13 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.069 0.948 . . . . 0.0 110.635 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 p -99.45 135.21 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.7 m -116.83 137.17 52.39 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.598 0.759 . . . . 0.0 111.365 -169.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.697 ' HE1' ' HB2' ' A' ' 4' ' ' ARG . 76.1 mtm . . . . . 0 C--O 1.251 1.144 0 C-N-CA 124.688 1.195 . . . . 0.0 110.855 -178.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 . . . . . 0 C--O 1.233 0.226 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.3 m -140.48 153.47 46.25 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.665 0.786 . . . . 0.0 109.565 173.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.0 p -138.2 142.43 39.99 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.983 1.313 . . . . 0.0 108.918 -176.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -74.46 92.48 2.35 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.608 0.763 . . . . 0.0 109.496 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.34 176.25 54.71 Favored Glycine 0 CA--C 1.533 1.162 0 N-CA-C 111.576 -0.609 . . . . 0.0 111.576 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.89 -43.09 62.72 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.971 3.114 . . . . 0.0 112.209 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -99.46 47.57 0.96 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.576 1.15 . . . . 0.0 109.585 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.69 -172.26 54.88 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -67.08 134.73 52.43 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.062 0.545 . . . . 0.0 111.453 -178.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.5 136.38 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 125.437 1.495 . . . . 0.0 107.878 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.2 m -106.92 139.55 41.15 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.349 1.06 . . . . 0.0 109.114 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 72.8 mtm . . . . . 0 C--O 1.25 1.092 0 CA-C-O 117.68 -1.152 . . . . 0.0 110.74 -169.133 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 . . . . . 0 CA--C 1.528 0.125 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 45.8 m -126.96 146.96 50.14 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.69 0.796 . . . . 0.0 109.789 173.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.8 p -129.51 123.31 31.16 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.814 1.246 . . . . 0.0 109.205 -176.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -69.64 119.84 14.49 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.19 -169.71 11.77 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.483 1.04 . . . . 0.0 111.072 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.02 -38.46 59.22 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 124.647 3.565 . . . . 0.0 113.488 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.3 m-90 -99.51 35.99 1.86 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.324 1.05 . . . . 0.0 110.74 -176.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.33 -157.89 43.13 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -70.07 113.02 6.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.918 0.487 . . . . 0.0 109.712 171.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.4 t -98.91 112.61 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.3 m -99.61 144.96 28.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.962 0.905 . . . . 0.0 111.131 -173.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 96.5 mmm . . . . . 0 C--O 1.252 1.191 0 C-N-CA 126.371 1.868 . . . . 0.0 108.888 179.717 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.5 m -139.77 154.24 47.35 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.678 0.791 . . . . 0.0 109.909 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.1 p -134.09 133.7 41.43 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.922 1.289 . . . . 0.0 108.891 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -76.21 79.82 3.01 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.701 0.8 . . . . 0.0 109.476 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.09 -168.44 44.78 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.3 0.952 . . . . 0.0 111.39 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.86 -38.32 57.38 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 124.606 3.537 . . . . 0.0 113.133 177.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -99.6 30.21 3.71 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.465 1.106 . . . . 0.0 110.882 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.55 -157.76 42.54 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -66.33 95.25 0.3 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.01 0.924 . . . . 0.0 110.69 178.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.1 m -99.52 133.4 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.1 m -108.84 143.83 37.51 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.198 0.999 . . . . 0.0 111.032 -170.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.9 ttp . . . . . 0 C--O 1.251 1.153 0 CA-C-O 116.969 -1.491 . . . . 0.0 109.448 -178.177 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.6 m -138.3 163.76 30.97 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.654 0.782 . . . . 0.0 109.209 171.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.5 t -144.93 145.74 31.68 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.064 0.945 . . . . 0.0 109.868 -175.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -69.32 125.14 25.78 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.14 -174.15 13.68 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.322 0.963 . . . . 0.0 111.016 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -53.5 -40.93 77.03 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.346 3.364 . . . . 0.0 113.046 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.2 m-90 -99.55 41.72 1.14 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.28 1.032 . . . . 0.0 110.196 -176.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.29 -159.62 45.14 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -70.0 103.98 2.41 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 173.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.7 m -99.58 136.71 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 124.798 1.239 . . . . 0.0 108.18 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.7 m -99.6 144.86 28.2 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.204 0.602 . . . . 0.0 111.206 -171.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 C--O 1.251 1.184 0 CA-C-O 117.368 -1.301 . . . . 0.0 109.387 -172.494 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 . . . . . 0 N--CA 1.457 -0.104 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 31.3 m -140.26 155.26 46.93 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.523 0.729 . . . . 0.0 109.175 169.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t -149.07 144.1 26.47 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.761 0.824 . . . . 0.0 109.868 -175.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -79.02 79.72 5.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.06 0.944 . . . . 0.0 109.257 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.76 -169.86 44.87 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.113 0.863 . . . . 0.0 111.45 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.13 -38.82 61.14 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 124.625 3.55 . . . . 0.0 113.09 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -99.6 33.34 2.53 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.483 1.113 . . . . 0.0 110.818 -177.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.52 -157.7 42.53 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -66.59 94.44 0.29 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.887 0.875 . . . . 0.0 110.78 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.8 m -99.66 137.74 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 124.851 1.261 . . . . 0.0 108.074 174.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.7 m -104.89 145.23 30.69 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.796 0.838 . . . . 0.0 110.896 -175.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 C--O 1.251 1.166 0 C-N-CA 125.966 1.706 . . . . 0.0 108.303 -173.083 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 57.5 m -140.04 141.99 36.23 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 169.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 t -134.81 138.15 43.99 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 123.902 0.881 . . . . 0.0 109.839 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -79.6 80.34 5.99 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.886 0.875 . . . . 0.0 109.339 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.75 -170.12 46.67 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.178 0.894 . . . . 0.0 111.331 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -51.32 -37.85 61.18 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 124.565 3.51 . . . . 0.0 113.073 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.8 m-90 -99.57 34.46 2.22 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.485 1.114 . . . . 0.0 110.784 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.37 -156.48 41.29 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -67.94 101.11 1.05 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.561 0.745 . . . . 0.0 110.471 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 73.9 t -99.07 119.34 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 176.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 71.6 m -99.79 143.13 30.38 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.083 0.953 . . . . 0.0 110.196 -178.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 24.6 ptp . . . . . 0 C--O 1.25 1.125 0 CA-C-O 117.148 -1.406 . . . . 0.0 110.49 -173.724 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 93.6 m -99.87 146.04 27.08 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.563 1.145 . . . . 0.0 110.697 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.1 t -145.73 144.38 30.32 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.63 1.172 . . . . 0.0 109.57 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -76.82 110.83 11.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.86 -173.63 14.83 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.759 1.171 . . . . 0.0 111.189 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -53.02 -40.78 75.39 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.267 3.311 . . . . 0.0 112.996 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.3 m-90 -99.63 42.53 1.1 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.276 1.031 . . . . 0.0 110.372 -176.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.33 -159.82 45.26 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -70.48 99.71 1.66 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.119 0.568 . . . . 0.0 109.902 173.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.3 m -99.55 146.97 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 124.855 1.262 . . . . 0.0 107.873 175.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.1 m -132.46 149.48 52.33 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 122.834 0.453 . . . . 0.0 110.99 -172.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.6 mmt . . . . . 0 C--O 1.25 1.125 0 CA-C-O 117.285 -1.341 . . . . 0.0 109.641 178.401 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 72.9 m -99.12 140.13 33.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.331 0.653 . . . . 0.0 110.652 -173.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 75.7 p -137.2 142.62 42.12 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.656 1.582 . . . . 0.0 108.363 -176.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -78.23 94.11 4.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.78 177.19 54.41 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.638 0.637 . . . . 0.0 111.542 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.3 -40.81 10.29 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.963 3.109 . . . . 0.0 110.975 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -99.41 53.74 0.95 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.924 0.89 . . . . 0.0 109.074 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.73 -175.89 54.86 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 123.693 0.663 . . . . 0.0 111.642 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 68.7 m95 -66.27 141.6 57.96 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.257 0.623 . . . . 0.0 111.261 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.9 p -139.26 138.94 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 125.448 1.499 . . . . 0.0 107.755 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.5 m -123.41 144.63 49.36 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.633 0.773 . . . . 0.0 110.936 -174.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 C--O 1.251 1.145 0 CA-C-O 117.082 -1.437 . . . . 0.0 110.184 179.624 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 33.0 ptt-85 . . . . . 0 N--CA 1.454 -0.237 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 27.3 m -140.13 151.55 45.39 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 122.741 0.416 . . . . 0.0 110.422 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -139.75 146.45 39.55 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.994 0.918 . . . . 0.0 109.873 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -78.7 79.08 5.13 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.133 0.973 . . . . 0.0 109.341 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.95 -165.7 41.51 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.498 1.047 . . . . 0.0 111.532 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -50.25 -39.01 52.81 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 124.956 3.771 . . . . 0.0 113.526 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -99.56 29.89 3.85 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.332 1.053 . . . . 0.0 110.88 -175.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.42 -154.93 39.1 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -65.2 92.25 0.11 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.819 0.848 . . . . 0.0 110.4 175.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.1 p -99.47 135.09 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 125.184 1.393 . . . . 0.0 107.589 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 77.2 m -112.5 149.28 32.88 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.146 0.978 . . . . 0.0 111.703 -169.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.164 0 CA-C-O 116.865 -1.54 . . . . 0.0 111.1 -177.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 . . . . . 0 N--CA 1.457 -0.116 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 70.9 m -140.06 140.16 36.07 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.733 0.813 . . . . 0.0 109.465 171.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.1 p -128.87 121.94 29.29 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.813 1.245 . . . . 0.0 108.984 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -68.91 121.22 16.14 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.22 -168.87 11.49 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.796 1.189 . . . . 0.0 110.624 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.39 -38.78 63.78 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.506 3.471 . . . . 0.0 113.394 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -99.6 38.03 1.5 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.342 1.057 . . . . 0.0 110.84 -175.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.29 -156.1 40.95 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -69.04 113.53 6.5 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 170.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.0 t -98.84 108.78 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.2 m -99.79 143.43 30.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.967 0.907 . . . . 0.0 111.116 -173.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 93.6 mmm . . . . . 0 C--O 1.251 1.14 0 C-N-CA 125.834 1.654 . . . . 0.0 108.637 -178.563 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.069 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -70.04 144.88 52.07 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.213 0.605 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 87.8 mt -69.37 147.99 97.16 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 123.352 0.661 . . . . 0.0 109.458 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.09 122.92 10.55 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.983 2.455 . . . . 0.0 110.063 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 69.8 ttt-85 -179.08 150.33 0.46 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -174.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 58.4 m -126.62 153.37 45.42 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.711 0.804 . . . . 0.0 110.424 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.5 p -139.52 143.79 37.6 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.256 1.423 . . . . 0.0 108.932 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.81 109.48 2.49 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -104.02 179.03 24.95 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.223 0.916 . . . . 0.0 111.106 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.81 -44.28 46.48 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.865 3.043 . . . . 0.0 112.023 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -99.47 48.38 0.95 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.53 1.132 . . . . 0.0 109.564 -176.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.53 -168.4 52.72 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -67.67 118.54 11.08 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.792 0.437 . . . . 0.0 110.652 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.3 m -99.73 147.62 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.5 m -128.98 144.45 51.19 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.694 0.798 . . . . 0.0 111.153 -173.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 C--O 1.251 1.172 0 C-N-CA 125.206 1.402 . . . . 0.0 109.479 177.333 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.004 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -83.53 38.11 0.61 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.279 1.032 . . . . 0.0 112.229 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 87.3 mt -137.8 130.89 16.77 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 124.963 1.305 . . . . 0.0 107.856 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -80.94 61.96 8.4 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.333 2.689 . . . . 0.0 109.666 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 -146.16 -170.96 3.61 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 124.875 1.27 . . . . 0.0 109.62 -174.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.9 m -140.03 159.68 41.64 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 123.729 0.812 . . . . 0.0 109.619 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.5 p -134.41 142.08 47.03 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.78 1.232 . . . . 0.0 109.024 -175.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -71.15 108.58 4.73 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -108.01 -179.06 22.08 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.413 1.006 . . . . 0.0 111.274 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.25 -43.42 56.23 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 124.056 3.17 . . . . 0.0 112.278 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.4 m-90 -99.44 47.05 0.96 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.451 1.1 . . . . 0.0 109.733 -175.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.44 -163.48 48.53 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -69.26 114.18 7.28 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.77 0.428 . . . . 0.0 110.407 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.1 m -99.59 127.49 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.0 m -99.87 152.23 20.39 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.404 0.681 . . . . 0.0 111.844 -170.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 C--O 1.249 1.063 0 C-N-CA 126.16 1.784 . . . . 0.0 109.306 -176.403 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.036 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -70.97 147.39 48.72 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.342 0.657 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.15 150.99 87.62 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 124.153 0.981 . . . . 0.0 110.888 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.69 95.83 0.29 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.788 2.992 . . . . 0.0 110.197 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -147.05 169.59 18.92 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 125.693 1.597 . . . . 0.0 108.824 -174.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 39.0 m -140.2 156.17 46.62 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 170.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -149.11 150.79 33.3 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.134 0.974 . . . . 0.0 109.712 -177.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -66.68 110.3 3.17 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.55 176.75 24.38 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.41 -43.37 58.98 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.814 3.009 . . . . 0.0 111.983 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -99.51 47.82 0.95 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.618 1.167 . . . . 0.0 109.718 -176.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.74 -170.86 54.36 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 49.6 m95 -65.76 112.46 3.73 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.116 0.566 . . . . 0.0 110.808 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.8 p -100.16 137.59 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.828 1.251 . . . . 0.0 108.382 176.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.0 m -105.23 150.79 24.81 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.823 0.849 . . . . 0.0 110.112 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 20.5 ptt? . . . . . 0 C--O 1.251 1.155 0 C-N-CA 125.531 1.533 . . . . 0.0 110.709 -169.509 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.011 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.4 t30 59.24 77.59 0.3 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.249 1.419 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.1 tp -154.27 137.36 10.26 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.86 69.16 7.02 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.126 2.551 . . . . 0.0 110.902 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -148.16 144.86 28.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 126.108 1.763 . . . . 0.0 107.563 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.3 m -139.53 163.15 33.31 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.638 0.775 . . . . 0.0 110.219 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.4 t -148.1 152.99 38.27 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.151 0.98 . . . . 0.0 109.619 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -76.88 94.02 3.84 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.658 0.783 . . . . 0.0 108.894 176.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.94 176.04 54.79 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.94 -43.24 61.29 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.993 3.128 . . . . 0.0 112.193 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -99.46 47.06 0.96 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.579 1.152 . . . . 0.0 109.565 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.78 -172.38 54.87 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -64.86 139.24 58.74 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.953 0.501 . . . . 0.0 111.843 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.1 p -139.29 141.05 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 125.377 1.471 . . . . 0.0 108.038 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.8 m -111.79 145.75 38.85 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.421 1.088 . . . . 0.0 110.26 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 28.5 ttt . . . . . 0 C--O 1.25 1.109 0 CA-C-O 117.678 -1.154 . . . . 0.0 110.502 -177.397 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.06 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -60.92 -37.43 82.29 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.982 0.913 . . . . 0.0 111.514 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 65.4 tp -120.14 87.79 40.09 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.73 67.3 8.68 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.734 2.956 . . . . 0.0 111.718 -167.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -108.01 -164.58 0.97 Allowed 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 125.657 1.583 . . . . 0.0 108.385 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -140.36 161.56 37.4 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 123.683 0.793 . . . . 0.0 109.985 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.5 t -147.88 152.21 37.2 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.448 1.099 . . . . 0.0 109.18 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -69.43 108.42 3.74 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 176.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.28 175.76 29.76 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.34 -44.52 45.45 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.766 2.978 . . . . 0.0 111.836 176.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.7 m-90 -99.59 49.6 0.93 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.551 1.14 . . . . 0.0 109.552 -176.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.8 -171.6 54.61 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -65.67 116.03 6.46 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.205 0.602 . . . . 0.0 110.999 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.1 p -99.94 138.98 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 124.849 1.26 . . . . 0.0 108.115 175.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.9 m -115.08 145.35 42.42 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.0 0.92 . . . . 0.0 110.513 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 C--O 1.251 1.142 0 CA-C-O 117.308 -1.33 . . . . 0.0 109.33 -178.736 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.031 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -157.95 161.68 38.2 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.128 0.971 . . . . 0.0 109.178 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.1 mp -61.06 153.29 67.28 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 124.274 1.029 . . . . 0.0 109.645 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -62.5 108.23 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.091 2.527 . . . . 0.0 108.843 174.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -151.65 148.37 27.86 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.35 1.06 . . . . 0.0 108.729 -164.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 81.6 m -140.03 149.09 42.76 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 123.53 0.732 . . . . 0.0 109.964 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.3 t -150.08 150.63 31.99 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.259 1.024 . . . . 0.0 109.704 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -69.43 109.31 4.14 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -101.86 178.78 27.35 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.031 0.824 . . . . 0.0 111.055 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -56.89 -44.32 45.93 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.863 3.042 . . . . 0.0 111.957 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.4 m-90 -99.46 49.09 0.94 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.545 1.138 . . . . 0.0 109.573 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.57 -168.17 52.46 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -176.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 56.0 m95 -67.76 116.2 8.18 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.934 0.493 . . . . 0.0 110.73 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.8 m -99.95 156.17 4.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 124.702 1.201 . . . . 0.0 108.138 173.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.1 m -136.23 145.71 45.95 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.099 0.56 . . . . 0.0 110.983 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 94.2 mmm . . . . . 0 C--O 1.251 1.167 0 C-N-CA 126.405 1.882 . . . . 0.0 109.946 -178.75 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.005 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 43.38 55.2 4.9 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.185 1.794 . . . . 0.0 113.038 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.5 pp -149.26 152.44 35.92 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 123.934 0.894 . . . . 0.0 110.142 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -84.62 64.89 6.63 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.448 2.766 . . . . 0.0 111.711 -172.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.5 mtm-85 -144.65 172.16 13.38 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.408 1.083 . . . . 0.0 109.022 170.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 19.9 m -134.96 157.82 45.92 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.986 0.915 . . . . 0.0 109.779 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 73.6 p -134.12 134.73 42.58 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.662 1.185 . . . . 0.0 109.271 -172.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -78.45 78.29 4.92 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.48 0.712 . . . . 0.0 109.197 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.38 -169.33 45.43 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.276 0.941 . . . . 0.0 111.601 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -51.01 -38.67 59.64 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 124.67 3.58 . . . . 0.0 113.048 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -99.59 32.02 2.97 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.426 1.091 . . . . 0.0 110.853 -177.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.54 -157.24 41.94 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -66.5 94.3 0.27 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.934 0.894 . . . . 0.0 110.781 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.4 m -99.57 131.94 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.2 m -99.44 144.34 28.66 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.226 0.61 . . . . 0.0 111.177 -169.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 58.0 mmm . . . . . 0 C--O 1.249 1.073 0 CA-C-O 116.763 -1.589 . . . . 0.0 110.879 -170.924 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.024 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 54.9 t30 53.67 62.94 2.39 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.352 1.461 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.2 tp -157.59 134.86 6.85 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -79.02 65.93 8.81 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.095 2.53 . . . . 0.0 110.423 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -154.14 166.53 32.78 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.519 1.528 . . . . 0.0 109.176 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 24.9 m -134.73 162.53 32.09 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.392 1.077 . . . . 0.0 109.343 175.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.2 p -137.82 142.58 40.79 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.996 1.318 . . . . 0.0 108.733 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -74.55 95.64 2.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.269 0.628 . . . . 0.0 109.355 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.84 178.04 53.98 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.697 0.665 . . . . 0.0 111.459 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.99 -41.85 9.24 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 124.003 3.135 . . . . 0.0 110.91 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -99.44 54.19 0.96 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.94 0.896 . . . . 0.0 109.018 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.76 -176.49 54.67 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 123.716 0.674 . . . . 0.0 111.723 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -65.54 140.02 58.52 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.459 0.704 . . . . 0.0 111.493 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -128.21 136.56 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 125.356 1.462 . . . . 0.0 107.625 174.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.8 m -110.34 148.48 31.88 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.141 0.976 . . . . 0.0 111.099 -174.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.4 mtm . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.443 1.497 . . . . 0.0 110.445 -177.789 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.036 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -72.88 163.77 27.64 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.543 0.737 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.4 tp -64.72 125.64 89.25 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 171.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.67 88.56 1.03 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.947 2.431 . . . . 0.0 109.449 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.2 mmm-85 -157.41 168.78 26.36 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.49 1.116 . . . . 0.0 109.577 -173.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 23.9 m -135.38 154.06 51.61 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.404 1.081 . . . . 0.0 108.795 173.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t -144.34 147.44 33.46 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.714 0.806 . . . . 0.0 109.945 -173.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -72.44 117.6 14.32 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.08 -167.77 11.12 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.522 1.058 . . . . 0.0 111.2 -176.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -51.04 -40.0 59.63 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.729 3.62 . . . . 0.0 113.739 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 -99.56 34.24 2.28 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.23 1.012 . . . . 0.0 110.697 -175.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.33 -156.79 41.79 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -65.98 97.46 0.36 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.995 0.518 . . . . 0.0 109.646 170.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.51 136.14 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.961 1.304 . . . . 0.0 108.17 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.2 m -99.73 146.38 26.6 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.659 0.784 . . . . 0.0 111.008 -174.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.6 mtt . . . . . 0 C--O 1.251 1.169 0 CA-C-O 117.513 -1.232 . . . . 0.0 110.283 -174.446 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.071 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -157.38 158.44 35.91 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.239 1.016 . . . . 0.0 109.031 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.87 159.35 70.24 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 123.654 0.782 . . . . 0.0 109.915 177.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -54.63 98.11 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.926 3.084 . . . . 0.0 112.826 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.697 ' HB2' ' HE1' ' A' ' 15' ' ' MET . 86.8 mmt-85 -129.3 106.48 8.84 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 68.6 m -99.32 138.12 36.86 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.844 0.858 . . . . 0.0 111.173 -169.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.2 p -137.27 132.06 33.21 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.536 1.534 . . . . 0.0 108.536 -175.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.04 79.78 2.89 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.573 0.749 . . . . 0.0 109.504 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.39 -166.74 42.15 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.542 1.067 . . . . 0.0 111.44 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.68 -38.0 54.92 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 124.803 3.669 . . . . 0.0 113.28 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -99.55 28.32 4.71 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.414 1.086 . . . . 0.0 110.965 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.48 -156.27 40.81 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -66.01 90.13 0.13 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.069 0.948 . . . . 0.0 110.635 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 p -99.45 135.21 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.7 m -116.83 137.17 52.39 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.598 0.759 . . . . 0.0 111.365 -169.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.697 ' HE1' ' HB2' ' A' ' 4' ' ' ARG . 76.1 mtm . . . . . 0 C--O 1.251 1.144 0 C-N-CA 124.688 1.195 . . . . 0.0 110.855 -178.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.006 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -65.61 -51.83 56.65 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.714 0.805 . . . . 0.0 109.149 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.3 mt -92.92 152.01 41.16 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.575 1.15 . . . . 0.0 108.184 171.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.48 78.52 3.01 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.466 2.777 . . . . 0.0 110.254 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -157.09 140.81 15.98 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.546 1.139 . . . . 0.0 109.101 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.3 m -140.48 153.47 46.25 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.665 0.786 . . . . 0.0 109.565 173.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.0 p -138.2 142.43 39.99 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.983 1.313 . . . . 0.0 108.918 -176.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -74.46 92.48 2.35 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.608 0.763 . . . . 0.0 109.496 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.34 176.25 54.71 Favored Glycine 0 CA--C 1.533 1.162 0 N-CA-C 111.576 -0.609 . . . . 0.0 111.576 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.89 -43.09 62.72 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.971 3.114 . . . . 0.0 112.209 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -99.46 47.57 0.96 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.576 1.15 . . . . 0.0 109.585 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.69 -172.26 54.88 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -67.08 134.73 52.43 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.062 0.545 . . . . 0.0 111.453 -178.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.5 136.38 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 125.437 1.495 . . . . 0.0 107.878 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.2 m -106.92 139.55 41.15 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.349 1.06 . . . . 0.0 109.114 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 72.8 mtm . . . . . 0 C--O 1.25 1.092 0 CA-C-O 117.68 -1.152 . . . . 0.0 110.74 -169.133 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.045 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -156.89 -132.23 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 pp -68.31 147.94 98.23 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 118.911 0.778 . . . . 0.0 109.914 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -70.27 98.01 0.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.778 2.985 . . . . 0.0 111.068 -174.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -165.6 154.54 11.88 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.637 1.175 . . . . 0.0 108.531 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 45.8 m -126.96 146.96 50.14 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.69 0.796 . . . . 0.0 109.789 173.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.8 p -129.51 123.31 31.16 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.814 1.246 . . . . 0.0 109.205 -176.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -69.64 119.84 14.49 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.19 -169.71 11.77 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.483 1.04 . . . . 0.0 111.072 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.02 -38.46 59.22 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 124.647 3.565 . . . . 0.0 113.488 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.3 m-90 -99.51 35.99 1.86 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.324 1.05 . . . . 0.0 110.74 -176.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.33 -157.89 43.13 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -70.07 113.02 6.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.918 0.487 . . . . 0.0 109.712 171.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.4 t -98.91 112.61 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.3 m -99.61 144.96 28.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.962 0.905 . . . . 0.0 111.131 -173.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 96.5 mmm . . . . . 0 C--O 1.252 1.191 0 C-N-CA 126.371 1.868 . . . . 0.0 108.888 179.717 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.048 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -63.6 -56.41 16.1 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 123.468 0.707 . . . . 0.0 109.296 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 38.3 tp -84.86 127.76 63.51 Favored Pre-proline 0 N--CA 1.451 -0.41 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 169.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -58.31 84.32 0.05 OUTLIER 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.914 3.076 . . . . 0.0 112.433 173.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 -165.07 137.13 4.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.005 1.322 . . . . 0.0 107.992 -176.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.5 m -139.77 154.24 47.35 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.678 0.791 . . . . 0.0 109.909 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.1 p -134.09 133.7 41.43 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.922 1.289 . . . . 0.0 108.891 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -76.21 79.82 3.01 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.701 0.8 . . . . 0.0 109.476 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.09 -168.44 44.78 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.3 0.952 . . . . 0.0 111.39 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.86 -38.32 57.38 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 124.606 3.537 . . . . 0.0 113.133 177.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -99.6 30.21 3.71 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.465 1.106 . . . . 0.0 110.882 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.55 -157.76 42.54 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -66.33 95.25 0.3 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.01 0.924 . . . . 0.0 110.69 178.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.1 m -99.52 133.4 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.1 m -108.84 143.83 37.51 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.198 0.999 . . . . 0.0 111.032 -170.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.9 ttp . . . . . 0 C--O 1.251 1.153 0 CA-C-O 116.969 -1.491 . . . . 0.0 109.448 -178.177 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.064 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -72.82 171.47 12.61 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.551 0.741 . . . . 0.0 110.327 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.3 mp -114.47 42.69 0.28 Allowed Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -174.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.64 -46.42 27.14 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.137 1.892 . . . . 0.0 110.718 154.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -155.07 179.0 9.56 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.449 1.099 . . . . 0.0 109.463 170.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.6 m -138.3 163.76 30.97 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.654 0.782 . . . . 0.0 109.209 171.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.5 t -144.93 145.74 31.68 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.064 0.945 . . . . 0.0 109.868 -175.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -69.32 125.14 25.78 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.14 -174.15 13.68 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.322 0.963 . . . . 0.0 111.016 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -53.5 -40.93 77.03 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.346 3.364 . . . . 0.0 113.046 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.2 m-90 -99.55 41.72 1.14 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.28 1.032 . . . . 0.0 110.196 -176.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.29 -159.62 45.14 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -70.0 103.98 2.41 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 173.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.7 m -99.58 136.71 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 124.798 1.239 . . . . 0.0 108.18 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.7 m -99.6 144.86 28.2 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.204 0.602 . . . . 0.0 111.206 -171.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 C--O 1.251 1.184 0 CA-C-O 117.368 -1.301 . . . . 0.0 109.387 -172.494 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.025 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -63.9 -53.1 55.69 Favored 'General case' 0 C--N 1.338 0.075 0 C-N-CA 123.745 0.818 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.8 tt -106.07 110.79 64.32 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 125.422 1.489 . . . . 0.0 107.03 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -46.66 114.26 0.87 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 124.068 3.178 . . . . 0.0 112.574 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -156.46 170.22 22.82 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 124.441 1.097 . . . . 0.0 109.496 -172.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 31.3 m -140.26 155.26 46.93 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.523 0.729 . . . . 0.0 109.175 169.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t -149.07 144.1 26.47 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.761 0.824 . . . . 0.0 109.868 -175.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -79.02 79.72 5.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.06 0.944 . . . . 0.0 109.257 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.76 -169.86 44.87 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.113 0.863 . . . . 0.0 111.45 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.13 -38.82 61.14 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 124.625 3.55 . . . . 0.0 113.09 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -99.6 33.34 2.53 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.483 1.113 . . . . 0.0 110.818 -177.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.52 -157.7 42.53 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -66.59 94.44 0.29 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.887 0.875 . . . . 0.0 110.78 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.8 m -99.66 137.74 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 124.851 1.261 . . . . 0.0 108.074 174.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.7 m -104.89 145.23 30.69 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.796 0.838 . . . . 0.0 110.896 -175.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 C--O 1.251 1.166 0 C-N-CA 125.966 1.706 . . . . 0.0 108.303 -173.083 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.025 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -160.74 175.43 12.63 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.485 1.114 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.45 150.55 54.64 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 123.575 0.75 . . . . 0.0 110.358 178.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.28 82.62 1.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.096 2.531 . . . . 0.0 111.708 -171.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -95.92 167.63 11.13 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.772 1.229 . . . . 0.0 108.917 170.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 57.5 m -140.04 141.99 36.23 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 169.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 t -134.81 138.15 43.99 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 123.902 0.881 . . . . 0.0 109.839 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -79.6 80.34 5.99 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.886 0.875 . . . . 0.0 109.339 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.75 -170.12 46.67 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.178 0.894 . . . . 0.0 111.331 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -51.32 -37.85 61.18 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 124.565 3.51 . . . . 0.0 113.073 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.8 m-90 -99.57 34.46 2.22 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.485 1.114 . . . . 0.0 110.784 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.37 -156.48 41.29 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -67.94 101.11 1.05 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.561 0.745 . . . . 0.0 110.471 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 73.9 t -99.07 119.34 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 176.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 71.6 m -99.79 143.13 30.38 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.083 0.953 . . . . 0.0 110.196 -178.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 24.6 ptp . . . . . 0 C--O 1.25 1.125 0 CA-C-O 117.148 -1.406 . . . . 0.0 110.49 -173.724 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.029 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 -61.64 -46.75 88.45 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.895 0.878 . . . . 0.0 111.049 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.0 mt -129.08 86.55 56.79 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 125.243 1.417 . . . . 0.0 108.089 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -52.67 107.01 0.16 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 124.434 3.423 . . . . 0.0 112.685 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -159.63 144.45 15.26 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.414 1.085 . . . . 0.0 108.089 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 93.6 m -99.87 146.04 27.08 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.563 1.145 . . . . 0.0 110.697 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.1 t -145.73 144.38 30.32 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.63 1.172 . . . . 0.0 109.57 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -76.82 110.83 11.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.86 -173.63 14.83 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.759 1.171 . . . . 0.0 111.189 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -53.02 -40.78 75.39 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.267 3.311 . . . . 0.0 112.996 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.3 m-90 -99.63 42.53 1.1 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.276 1.031 . . . . 0.0 110.372 -176.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.33 -159.82 45.26 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -70.48 99.71 1.66 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.119 0.568 . . . . 0.0 109.902 173.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.3 m -99.55 146.97 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 124.855 1.262 . . . . 0.0 107.873 175.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.1 m -132.46 149.48 52.33 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 122.834 0.453 . . . . 0.0 110.99 -172.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.6 mmt . . . . . 0 C--O 1.25 1.125 0 CA-C-O 117.285 -1.341 . . . . 0.0 109.641 178.401 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.021 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -65.86 -46.18 79.4 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 123.526 0.731 . . . . 0.0 110.346 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 pp -64.21 150.66 92.12 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.102 0.961 . . . . 0.0 109.753 174.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.24 74.07 4.24 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.734 2.956 . . . . 0.0 111.378 -175.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -75.19 104.68 5.86 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 172.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 72.9 m -99.12 140.13 33.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.331 0.653 . . . . 0.0 110.652 -173.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 75.7 p -137.2 142.62 42.12 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.656 1.582 . . . . 0.0 108.363 -176.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -78.23 94.11 4.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.78 177.19 54.41 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.638 0.637 . . . . 0.0 111.542 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.3 -40.81 10.29 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.963 3.109 . . . . 0.0 110.975 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -99.41 53.74 0.95 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.924 0.89 . . . . 0.0 109.074 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.73 -175.89 54.86 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 123.693 0.663 . . . . 0.0 111.642 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 68.7 m95 -66.27 141.6 57.96 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.257 0.623 . . . . 0.0 111.261 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.9 p -139.26 138.94 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 125.448 1.499 . . . . 0.0 107.755 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.5 m -123.41 144.63 49.36 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.633 0.773 . . . . 0.0 110.936 -174.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 C--O 1.251 1.145 0 CA-C-O 117.082 -1.437 . . . . 0.0 110.184 179.624 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.021 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -67.44 -52.58 37.9 Favored 'General case' 0 CA--C 1.526 0.053 0 C-N-CA 123.9 0.88 . . . . 0.0 108.808 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.9 tt -143.13 97.98 5.64 Favored Pre-proline 0 N--CA 1.451 -0.391 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 171.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -40.51 102.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.571 1 C-N-CA 125.393 4.062 . . . . 0.0 114.583 -173.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 33.0 ptt-85 -157.51 160.38 38.17 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.701 1.6 . . . . 0.0 107.998 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 27.3 m -140.13 151.55 45.39 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 122.741 0.416 . . . . 0.0 110.422 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -139.75 146.45 39.55 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.994 0.918 . . . . 0.0 109.873 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -78.7 79.08 5.13 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.133 0.973 . . . . 0.0 109.341 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.95 -165.7 41.51 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.498 1.047 . . . . 0.0 111.532 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -50.25 -39.01 52.81 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 124.956 3.771 . . . . 0.0 113.526 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -99.56 29.89 3.85 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.332 1.053 . . . . 0.0 110.88 -175.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.42 -154.93 39.1 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -65.2 92.25 0.11 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.819 0.848 . . . . 0.0 110.4 175.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.1 p -99.47 135.09 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 125.184 1.393 . . . . 0.0 107.589 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 77.2 m -112.5 149.28 32.88 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.146 0.978 . . . . 0.0 111.703 -169.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.164 0 CA-C-O 116.865 -1.54 . . . . 0.0 111.1 -177.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.014 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.3 t30 69.61 -73.18 0.09 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 126.528 1.931 . . . . 0.0 111.724 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 pp -74.54 164.17 63.17 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 124.225 1.01 . . . . 0.0 109.413 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -45.33 93.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.717 1 C-N-CA 125.456 4.104 . . . . 0.0 114.946 -174.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -149.99 162.07 41.08 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 126.249 1.82 . . . . 0.0 108.232 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 70.9 m -140.06 140.16 36.07 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.733 0.813 . . . . 0.0 109.465 171.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.1 p -128.87 121.94 29.29 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.813 1.245 . . . . 0.0 108.984 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -68.91 121.22 16.14 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.22 -168.87 11.49 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.796 1.189 . . . . 0.0 110.624 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.39 -38.78 63.78 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.506 3.471 . . . . 0.0 113.394 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -99.6 38.03 1.5 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.342 1.057 . . . . 0.0 110.84 -175.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.29 -156.1 40.95 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -69.04 113.53 6.5 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 170.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.0 t -98.84 108.78 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.2 m -99.79 143.43 30.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.967 0.907 . . . . 0.0 111.116 -173.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 93.6 mmm . . . . . 0 C--O 1.251 1.14 0 C-N-CA 125.834 1.654 . . . . 0.0 108.637 -178.563 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 69.8 ttt-85 . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 58.4 m -126.62 153.37 45.42 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.711 0.804 . . . . 0.0 110.424 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.5 p -139.52 143.79 37.6 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.256 1.423 . . . . 0.0 108.932 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.81 109.48 2.49 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -104.02 179.03 24.95 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.223 0.916 . . . . 0.0 111.106 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.81 -44.28 46.48 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.865 3.043 . . . . 0.0 112.023 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -99.47 48.38 0.95 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.53 1.132 . . . . 0.0 109.564 -176.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.53 -168.4 52.72 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -67.67 118.54 11.08 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.792 0.437 . . . . 0.0 110.652 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.3 m -99.73 147.62 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.5 m -128.98 144.45 51.19 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.694 0.798 . . . . 0.0 111.153 -173.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 C--O 1.251 1.172 0 C-N-CA 125.206 1.402 . . . . 0.0 109.479 177.333 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 . . . . . 0 CA--C 1.527 0.086 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.9 m -140.03 159.68 41.64 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 123.729 0.812 . . . . 0.0 109.619 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.5 p -134.41 142.08 47.03 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.78 1.232 . . . . 0.0 109.024 -175.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -71.15 108.58 4.73 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -108.01 -179.06 22.08 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.413 1.006 . . . . 0.0 111.274 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.25 -43.42 56.23 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 124.056 3.17 . . . . 0.0 112.278 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.4 m-90 -99.44 47.05 0.96 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.451 1.1 . . . . 0.0 109.733 -175.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.44 -163.48 48.53 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -69.26 114.18 7.28 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.77 0.428 . . . . 0.0 110.407 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.1 m -99.59 127.49 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.0 m -99.87 152.23 20.39 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.404 0.681 . . . . 0.0 111.844 -170.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 C--O 1.249 1.063 0 C-N-CA 126.16 1.784 . . . . 0.0 109.306 -176.403 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 . . . . . 0 CA--C 1.529 0.137 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 39.0 m -140.2 156.17 46.62 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 170.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -149.11 150.79 33.3 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.134 0.974 . . . . 0.0 109.712 -177.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -66.68 110.3 3.17 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.55 176.75 24.38 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.41 -43.37 58.98 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.814 3.009 . . . . 0.0 111.983 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -99.51 47.82 0.95 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.618 1.167 . . . . 0.0 109.718 -176.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.74 -170.86 54.36 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 49.6 m95 -65.76 112.46 3.73 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.116 0.566 . . . . 0.0 110.808 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.8 p -100.16 137.59 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.828 1.251 . . . . 0.0 108.382 176.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.0 m -105.23 150.79 24.81 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.823 0.849 . . . . 0.0 110.112 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 20.5 ptt? . . . . . 0 C--O 1.251 1.155 0 C-N-CA 125.531 1.533 . . . . 0.0 110.709 -169.509 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.3 m -139.53 163.15 33.31 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.638 0.775 . . . . 0.0 110.219 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.4 t -148.1 152.99 38.27 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.151 0.98 . . . . 0.0 109.619 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -76.88 94.02 3.84 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.658 0.783 . . . . 0.0 108.894 176.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.94 176.04 54.79 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.94 -43.24 61.29 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.993 3.128 . . . . 0.0 112.193 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -99.46 47.06 0.96 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.579 1.152 . . . . 0.0 109.565 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.78 -172.38 54.87 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -64.86 139.24 58.74 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.953 0.501 . . . . 0.0 111.843 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.1 p -139.29 141.05 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 125.377 1.471 . . . . 0.0 108.038 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.8 m -111.79 145.75 38.85 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.421 1.088 . . . . 0.0 110.26 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 28.5 ttt . . . . . 0 C--O 1.25 1.109 0 CA-C-O 117.678 -1.154 . . . . 0.0 110.502 -177.397 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? . . . . . 0 CA--C 1.529 0.137 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -140.36 161.56 37.4 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 123.683 0.793 . . . . 0.0 109.985 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.5 t -147.88 152.21 37.2 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.448 1.099 . . . . 0.0 109.18 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -69.43 108.42 3.74 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 176.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.28 175.76 29.76 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.34 -44.52 45.45 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.766 2.978 . . . . 0.0 111.836 176.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.7 m-90 -99.59 49.6 0.93 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.551 1.14 . . . . 0.0 109.552 -176.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.8 -171.6 54.61 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -65.67 116.03 6.46 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.205 0.602 . . . . 0.0 110.999 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.1 p -99.94 138.98 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 124.849 1.26 . . . . 0.0 108.115 175.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.9 m -115.08 145.35 42.42 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.0 0.92 . . . . 0.0 110.513 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 C--O 1.251 1.142 0 CA-C-O 117.308 -1.33 . . . . 0.0 109.33 -178.736 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 81.6 m -140.03 149.09 42.76 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 123.53 0.732 . . . . 0.0 109.964 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.3 t -150.08 150.63 31.99 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.259 1.024 . . . . 0.0 109.704 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -69.43 109.31 4.14 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -101.86 178.78 27.35 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.031 0.824 . . . . 0.0 111.055 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -56.89 -44.32 45.93 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.863 3.042 . . . . 0.0 111.957 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.4 m-90 -99.46 49.09 0.94 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.545 1.138 . . . . 0.0 109.573 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.57 -168.17 52.46 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -176.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 56.0 m95 -67.76 116.2 8.18 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.934 0.493 . . . . 0.0 110.73 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.8 m -99.95 156.17 4.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 124.702 1.201 . . . . 0.0 108.138 173.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.1 m -136.23 145.71 45.95 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.099 0.56 . . . . 0.0 110.983 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 94.2 mmm . . . . . 0 C--O 1.251 1.167 0 C-N-CA 126.405 1.882 . . . . 0.0 109.946 -178.75 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.5 mtm-85 . . . . . 0 C--O 1.232 0.142 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 19.9 m -134.96 157.82 45.92 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.986 0.915 . . . . 0.0 109.779 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 73.6 p -134.12 134.73 42.58 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.662 1.185 . . . . 0.0 109.271 -172.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -78.45 78.29 4.92 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.48 0.712 . . . . 0.0 109.197 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.38 -169.33 45.43 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.276 0.941 . . . . 0.0 111.601 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -51.01 -38.67 59.64 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 124.67 3.58 . . . . 0.0 113.048 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -99.59 32.02 2.97 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.426 1.091 . . . . 0.0 110.853 -177.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.54 -157.24 41.94 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -66.5 94.3 0.27 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.934 0.894 . . . . 0.0 110.781 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.4 m -99.57 131.94 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.2 m -99.44 144.34 28.66 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.226 0.61 . . . . 0.0 111.177 -169.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 58.0 mmm . . . . . 0 C--O 1.249 1.073 0 CA-C-O 116.763 -1.589 . . . . 0.0 110.879 -170.924 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 24.9 m -134.73 162.53 32.09 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.392 1.077 . . . . 0.0 109.343 175.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.2 p -137.82 142.58 40.79 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.996 1.318 . . . . 0.0 108.733 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -74.55 95.64 2.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.269 0.628 . . . . 0.0 109.355 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.84 178.04 53.98 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.697 0.665 . . . . 0.0 111.459 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.99 -41.85 9.24 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 124.003 3.135 . . . . 0.0 110.91 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -99.44 54.19 0.96 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.94 0.896 . . . . 0.0 109.018 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.76 -176.49 54.67 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 123.716 0.674 . . . . 0.0 111.723 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -65.54 140.02 58.52 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.459 0.704 . . . . 0.0 111.493 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -128.21 136.56 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 125.356 1.462 . . . . 0.0 107.625 174.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.8 m -110.34 148.48 31.88 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.141 0.976 . . . . 0.0 111.099 -174.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.4 mtm . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.443 1.497 . . . . 0.0 110.445 -177.789 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.2 mmm-85 . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 23.9 m -135.38 154.06 51.61 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.404 1.081 . . . . 0.0 108.795 173.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t -144.34 147.44 33.46 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.714 0.806 . . . . 0.0 109.945 -173.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -72.44 117.6 14.32 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.08 -167.77 11.12 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.522 1.058 . . . . 0.0 111.2 -176.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -51.04 -40.0 59.63 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.729 3.62 . . . . 0.0 113.739 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 -99.56 34.24 2.28 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.23 1.012 . . . . 0.0 110.697 -175.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.33 -156.79 41.79 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -65.98 97.46 0.36 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.995 0.518 . . . . 0.0 109.646 170.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.51 136.14 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.961 1.304 . . . . 0.0 108.17 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.2 m -99.73 146.38 26.6 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.659 0.784 . . . . 0.0 111.008 -174.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.6 mtt . . . . . 0 C--O 1.251 1.169 0 CA-C-O 117.513 -1.232 . . . . 0.0 110.283 -174.446 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 86.8 mmt-85 . . . . . 0 N--CA 1.456 -0.153 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 68.6 m -99.32 138.12 36.86 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.844 0.858 . . . . 0.0 111.173 -169.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.2 p -137.27 132.06 33.21 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.536 1.534 . . . . 0.0 108.536 -175.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.04 79.78 2.89 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.573 0.749 . . . . 0.0 109.504 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.39 -166.74 42.15 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.542 1.067 . . . . 0.0 111.44 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.68 -38.0 54.92 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 124.803 3.669 . . . . 0.0 113.28 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -99.55 28.32 4.71 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.414 1.086 . . . . 0.0 110.965 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.48 -156.27 40.81 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -66.01 90.13 0.13 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.069 0.948 . . . . 0.0 110.635 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 p -99.45 135.21 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.7 m -116.83 137.17 52.39 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.598 0.759 . . . . 0.0 111.365 -169.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 76.1 mtm . . . . . 0 C--O 1.251 1.144 0 C-N-CA 124.688 1.195 . . . . 0.0 110.855 -178.036 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 . . . . . 0 C--O 1.233 0.226 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.3 m -140.48 153.47 46.25 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.665 0.786 . . . . 0.0 109.565 173.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.0 p -138.2 142.43 39.99 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.983 1.313 . . . . 0.0 108.918 -176.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -74.46 92.48 2.35 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.608 0.763 . . . . 0.0 109.496 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.34 176.25 54.71 Favored Glycine 0 CA--C 1.533 1.162 0 N-CA-C 111.576 -0.609 . . . . 0.0 111.576 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.89 -43.09 62.72 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.971 3.114 . . . . 0.0 112.209 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -99.46 47.57 0.96 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.576 1.15 . . . . 0.0 109.585 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.69 -172.26 54.88 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -67.08 134.73 52.43 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.062 0.545 . . . . 0.0 111.453 -178.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.5 136.38 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 125.437 1.495 . . . . 0.0 107.878 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.2 m -106.92 139.55 41.15 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.349 1.06 . . . . 0.0 109.114 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 72.8 mtm . . . . . 0 C--O 1.25 1.092 0 CA-C-O 117.68 -1.152 . . . . 0.0 110.74 -169.133 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 . . . . . 0 CA--C 1.528 0.125 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 45.8 m -126.96 146.96 50.14 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.69 0.796 . . . . 0.0 109.789 173.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.8 p -129.51 123.31 31.16 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.814 1.246 . . . . 0.0 109.205 -176.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -69.64 119.84 14.49 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.19 -169.71 11.77 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.483 1.04 . . . . 0.0 111.072 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.02 -38.46 59.22 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 124.647 3.565 . . . . 0.0 113.488 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.3 m-90 -99.51 35.99 1.86 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.324 1.05 . . . . 0.0 110.74 -176.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.33 -157.89 43.13 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -70.07 113.02 6.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.918 0.487 . . . . 0.0 109.712 171.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.4 t -98.91 112.61 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.3 m -99.61 144.96 28.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.962 0.905 . . . . 0.0 111.131 -173.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 96.5 mmm . . . . . 0 C--O 1.252 1.191 0 C-N-CA 126.371 1.868 . . . . 0.0 108.888 179.717 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.5 m -139.77 154.24 47.35 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.678 0.791 . . . . 0.0 109.909 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.1 p -134.09 133.7 41.43 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.922 1.289 . . . . 0.0 108.891 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -76.21 79.82 3.01 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.701 0.8 . . . . 0.0 109.476 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.09 -168.44 44.78 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.3 0.952 . . . . 0.0 111.39 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.86 -38.32 57.38 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 124.606 3.537 . . . . 0.0 113.133 177.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -99.6 30.21 3.71 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.465 1.106 . . . . 0.0 110.882 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.55 -157.76 42.54 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -66.33 95.25 0.3 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.01 0.924 . . . . 0.0 110.69 178.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.1 m -99.52 133.4 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.1 m -108.84 143.83 37.51 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.198 0.999 . . . . 0.0 111.032 -170.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.9 ttp . . . . . 0 C--O 1.251 1.153 0 CA-C-O 116.969 -1.491 . . . . 0.0 109.448 -178.177 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.6 m -138.3 163.76 30.97 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.654 0.782 . . . . 0.0 109.209 171.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.5 t -144.93 145.74 31.68 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.064 0.945 . . . . 0.0 109.868 -175.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -69.32 125.14 25.78 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.14 -174.15 13.68 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.322 0.963 . . . . 0.0 111.016 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -53.5 -40.93 77.03 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.346 3.364 . . . . 0.0 113.046 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.2 m-90 -99.55 41.72 1.14 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.28 1.032 . . . . 0.0 110.196 -176.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.29 -159.62 45.14 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -70.0 103.98 2.41 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 173.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.7 m -99.58 136.71 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 124.798 1.239 . . . . 0.0 108.18 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.7 m -99.6 144.86 28.2 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.204 0.602 . . . . 0.0 111.206 -171.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 C--O 1.251 1.184 0 CA-C-O 117.368 -1.301 . . . . 0.0 109.387 -172.494 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 . . . . . 0 N--CA 1.457 -0.104 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 31.3 m -140.26 155.26 46.93 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.523 0.729 . . . . 0.0 109.175 169.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t -149.07 144.1 26.47 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.761 0.824 . . . . 0.0 109.868 -175.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -79.02 79.72 5.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.06 0.944 . . . . 0.0 109.257 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.76 -169.86 44.87 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.113 0.863 . . . . 0.0 111.45 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.13 -38.82 61.14 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 124.625 3.55 . . . . 0.0 113.09 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -99.6 33.34 2.53 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.483 1.113 . . . . 0.0 110.818 -177.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.52 -157.7 42.53 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -66.59 94.44 0.29 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.887 0.875 . . . . 0.0 110.78 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.8 m -99.66 137.74 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 124.851 1.261 . . . . 0.0 108.074 174.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.7 m -104.89 145.23 30.69 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.796 0.838 . . . . 0.0 110.896 -175.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 C--O 1.251 1.166 0 C-N-CA 125.966 1.706 . . . . 0.0 108.303 -173.083 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 57.5 m -140.04 141.99 36.23 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 169.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 t -134.81 138.15 43.99 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 123.902 0.881 . . . . 0.0 109.839 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -79.6 80.34 5.99 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.886 0.875 . . . . 0.0 109.339 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.75 -170.12 46.67 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.178 0.894 . . . . 0.0 111.331 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -51.32 -37.85 61.18 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 124.565 3.51 . . . . 0.0 113.073 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.8 m-90 -99.57 34.46 2.22 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.485 1.114 . . . . 0.0 110.784 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.37 -156.48 41.29 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -67.94 101.11 1.05 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.561 0.745 . . . . 0.0 110.471 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 73.9 t -99.07 119.34 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 176.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 71.6 m -99.79 143.13 30.38 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.083 0.953 . . . . 0.0 110.196 -178.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 24.6 ptp . . . . . 0 C--O 1.25 1.125 0 CA-C-O 117.148 -1.406 . . . . 0.0 110.49 -173.724 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 93.6 m -99.87 146.04 27.08 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.563 1.145 . . . . 0.0 110.697 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.1 t -145.73 144.38 30.32 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.63 1.172 . . . . 0.0 109.57 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -76.82 110.83 11.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.86 -173.63 14.83 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.759 1.171 . . . . 0.0 111.189 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -53.02 -40.78 75.39 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.267 3.311 . . . . 0.0 112.996 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.3 m-90 -99.63 42.53 1.1 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.276 1.031 . . . . 0.0 110.372 -176.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.33 -159.82 45.26 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -70.48 99.71 1.66 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.119 0.568 . . . . 0.0 109.902 173.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.3 m -99.55 146.97 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 124.855 1.262 . . . . 0.0 107.873 175.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.1 m -132.46 149.48 52.33 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 122.834 0.453 . . . . 0.0 110.99 -172.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.6 mmt . . . . . 0 C--O 1.25 1.125 0 CA-C-O 117.285 -1.341 . . . . 0.0 109.641 178.401 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 72.9 m -99.12 140.13 33.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.331 0.653 . . . . 0.0 110.652 -173.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 75.7 p -137.2 142.62 42.12 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.656 1.582 . . . . 0.0 108.363 -176.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -78.23 94.11 4.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.78 177.19 54.41 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.638 0.637 . . . . 0.0 111.542 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.3 -40.81 10.29 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.963 3.109 . . . . 0.0 110.975 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -99.41 53.74 0.95 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.924 0.89 . . . . 0.0 109.074 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.73 -175.89 54.86 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 123.693 0.663 . . . . 0.0 111.642 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 68.7 m95 -66.27 141.6 57.96 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.257 0.623 . . . . 0.0 111.261 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.9 p -139.26 138.94 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 125.448 1.499 . . . . 0.0 107.755 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.5 m -123.41 144.63 49.36 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.633 0.773 . . . . 0.0 110.936 -174.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 C--O 1.251 1.145 0 CA-C-O 117.082 -1.437 . . . . 0.0 110.184 179.624 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 33.0 ptt-85 . . . . . 0 N--CA 1.454 -0.237 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 27.3 m -140.13 151.55 45.39 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 122.741 0.416 . . . . 0.0 110.422 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -139.75 146.45 39.55 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.994 0.918 . . . . 0.0 109.873 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -78.7 79.08 5.13 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.133 0.973 . . . . 0.0 109.341 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.95 -165.7 41.51 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.498 1.047 . . . . 0.0 111.532 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -50.25 -39.01 52.81 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 124.956 3.771 . . . . 0.0 113.526 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -99.56 29.89 3.85 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.332 1.053 . . . . 0.0 110.88 -175.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.42 -154.93 39.1 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -65.2 92.25 0.11 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.819 0.848 . . . . 0.0 110.4 175.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.1 p -99.47 135.09 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 125.184 1.393 . . . . 0.0 107.589 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 77.2 m -112.5 149.28 32.88 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.146 0.978 . . . . 0.0 111.703 -169.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.164 0 CA-C-O 116.865 -1.54 . . . . 0.0 111.1 -177.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 . . . . . 0 N--CA 1.457 -0.116 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 70.9 m -140.06 140.16 36.07 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.733 0.813 . . . . 0.0 109.465 171.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.1 p -128.87 121.94 29.29 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.813 1.245 . . . . 0.0 108.984 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -68.91 121.22 16.14 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.22 -168.87 11.49 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.796 1.189 . . . . 0.0 110.624 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.39 -38.78 63.78 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.506 3.471 . . . . 0.0 113.394 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -99.6 38.03 1.5 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.342 1.057 . . . . 0.0 110.84 -175.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.29 -156.1 40.95 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -69.04 113.53 6.5 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 170.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.0 t -98.84 108.78 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.2 m -99.79 143.43 30.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.967 0.907 . . . . 0.0 111.116 -173.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 93.6 mmm . . . . . 0 C--O 1.251 1.14 0 C-N-CA 125.834 1.654 . . . . 0.0 108.637 -178.563 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.069 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -70.04 144.88 52.07 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.213 0.605 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 87.8 mt -69.37 147.99 97.16 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 123.352 0.661 . . . . 0.0 109.458 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.09 122.92 10.55 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.983 2.455 . . . . 0.0 110.063 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 69.8 ttt-85 -179.08 150.33 0.46 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -174.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 58.4 m -126.62 153.37 45.42 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.711 0.804 . . . . 0.0 110.424 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.5 p -139.52 143.79 37.6 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.256 1.423 . . . . 0.0 108.932 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.81 109.48 2.49 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -104.02 179.03 24.95 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.223 0.916 . . . . 0.0 111.106 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.81 -44.28 46.48 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.865 3.043 . . . . 0.0 112.023 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -99.47 48.38 0.95 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.53 1.132 . . . . 0.0 109.564 -176.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.53 -168.4 52.72 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -67.67 118.54 11.08 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.792 0.437 . . . . 0.0 110.652 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.3 m -99.73 147.62 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.5 m -128.98 144.45 51.19 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.694 0.798 . . . . 0.0 111.153 -173.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 C--O 1.251 1.172 0 C-N-CA 125.206 1.402 . . . . 0.0 109.479 177.333 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.004 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -83.53 38.11 0.61 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.279 1.032 . . . . 0.0 112.229 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 87.3 mt -137.8 130.89 16.77 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 124.963 1.305 . . . . 0.0 107.856 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -80.94 61.96 8.4 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.333 2.689 . . . . 0.0 109.666 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 -146.16 -170.96 3.61 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 124.875 1.27 . . . . 0.0 109.62 -174.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.9 m -140.03 159.68 41.64 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 123.729 0.812 . . . . 0.0 109.619 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.5 p -134.41 142.08 47.03 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.78 1.232 . . . . 0.0 109.024 -175.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -71.15 108.58 4.73 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -108.01 -179.06 22.08 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.413 1.006 . . . . 0.0 111.274 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.25 -43.42 56.23 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 124.056 3.17 . . . . 0.0 112.278 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.4 m-90 -99.44 47.05 0.96 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.451 1.1 . . . . 0.0 109.733 -175.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.44 -163.48 48.53 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -69.26 114.18 7.28 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.77 0.428 . . . . 0.0 110.407 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.1 m -99.59 127.49 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.0 m -99.87 152.23 20.39 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.404 0.681 . . . . 0.0 111.844 -170.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 C--O 1.249 1.063 0 C-N-CA 126.16 1.784 . . . . 0.0 109.306 -176.403 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.036 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -70.97 147.39 48.72 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.342 0.657 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.15 150.99 87.62 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 124.153 0.981 . . . . 0.0 110.888 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.69 95.83 0.29 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.788 2.992 . . . . 0.0 110.197 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -147.05 169.59 18.92 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 125.693 1.597 . . . . 0.0 108.824 -174.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 39.0 m -140.2 156.17 46.62 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 170.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -149.11 150.79 33.3 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.134 0.974 . . . . 0.0 109.712 -177.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -66.68 110.3 3.17 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.55 176.75 24.38 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.41 -43.37 58.98 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.814 3.009 . . . . 0.0 111.983 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -99.51 47.82 0.95 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.618 1.167 . . . . 0.0 109.718 -176.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.74 -170.86 54.36 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 49.6 m95 -65.76 112.46 3.73 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.116 0.566 . . . . 0.0 110.808 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.8 p -100.16 137.59 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.828 1.251 . . . . 0.0 108.382 176.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.0 m -105.23 150.79 24.81 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.823 0.849 . . . . 0.0 110.112 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 20.5 ptt? . . . . . 0 C--O 1.251 1.155 0 C-N-CA 125.531 1.533 . . . . 0.0 110.709 -169.509 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.011 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.4 t30 59.24 77.59 0.3 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.249 1.419 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.1 tp -154.27 137.36 10.26 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.86 69.16 7.02 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.126 2.551 . . . . 0.0 110.902 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -148.16 144.86 28.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 126.108 1.763 . . . . 0.0 107.563 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.3 m -139.53 163.15 33.31 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.638 0.775 . . . . 0.0 110.219 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.4 t -148.1 152.99 38.27 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.151 0.98 . . . . 0.0 109.619 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -76.88 94.02 3.84 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.658 0.783 . . . . 0.0 108.894 176.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.94 176.04 54.79 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.94 -43.24 61.29 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.993 3.128 . . . . 0.0 112.193 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -99.46 47.06 0.96 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.579 1.152 . . . . 0.0 109.565 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.78 -172.38 54.87 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -64.86 139.24 58.74 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.953 0.501 . . . . 0.0 111.843 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.1 p -139.29 141.05 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 125.377 1.471 . . . . 0.0 108.038 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.8 m -111.79 145.75 38.85 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.421 1.088 . . . . 0.0 110.26 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 28.5 ttt . . . . . 0 C--O 1.25 1.109 0 CA-C-O 117.678 -1.154 . . . . 0.0 110.502 -177.397 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.06 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -60.92 -37.43 82.29 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.982 0.913 . . . . 0.0 111.514 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 65.4 tp -120.14 87.79 40.09 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.73 67.3 8.68 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.734 2.956 . . . . 0.0 111.718 -167.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -108.01 -164.58 0.97 Allowed 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 125.657 1.583 . . . . 0.0 108.385 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -140.36 161.56 37.4 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 123.683 0.793 . . . . 0.0 109.985 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.5 t -147.88 152.21 37.2 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.448 1.099 . . . . 0.0 109.18 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -69.43 108.42 3.74 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 176.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.28 175.76 29.76 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.34 -44.52 45.45 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.766 2.978 . . . . 0.0 111.836 176.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.7 m-90 -99.59 49.6 0.93 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.551 1.14 . . . . 0.0 109.552 -176.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.8 -171.6 54.61 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -65.67 116.03 6.46 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.205 0.602 . . . . 0.0 110.999 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.1 p -99.94 138.98 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 124.849 1.26 . . . . 0.0 108.115 175.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.9 m -115.08 145.35 42.42 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.0 0.92 . . . . 0.0 110.513 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 C--O 1.251 1.142 0 CA-C-O 117.308 -1.33 . . . . 0.0 109.33 -178.736 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.031 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -157.95 161.68 38.2 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.128 0.971 . . . . 0.0 109.178 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.1 mp -61.06 153.29 67.28 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 124.274 1.029 . . . . 0.0 109.645 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -62.5 108.23 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.091 2.527 . . . . 0.0 108.843 174.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -151.65 148.37 27.86 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.35 1.06 . . . . 0.0 108.729 -164.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 81.6 m -140.03 149.09 42.76 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 123.53 0.732 . . . . 0.0 109.964 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.3 t -150.08 150.63 31.99 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.259 1.024 . . . . 0.0 109.704 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -69.43 109.31 4.14 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -101.86 178.78 27.35 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.031 0.824 . . . . 0.0 111.055 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -56.89 -44.32 45.93 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.863 3.042 . . . . 0.0 111.957 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.4 m-90 -99.46 49.09 0.94 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.545 1.138 . . . . 0.0 109.573 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.57 -168.17 52.46 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -176.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 56.0 m95 -67.76 116.2 8.18 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.934 0.493 . . . . 0.0 110.73 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.8 m -99.95 156.17 4.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 124.702 1.201 . . . . 0.0 108.138 173.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.1 m -136.23 145.71 45.95 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.099 0.56 . . . . 0.0 110.983 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 94.2 mmm . . . . . 0 C--O 1.251 1.167 0 C-N-CA 126.405 1.882 . . . . 0.0 109.946 -178.75 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.005 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 43.38 55.2 4.9 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.185 1.794 . . . . 0.0 113.038 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.5 pp -149.26 152.44 35.92 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 123.934 0.894 . . . . 0.0 110.142 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -84.62 64.89 6.63 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.448 2.766 . . . . 0.0 111.711 -172.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.5 mtm-85 -144.65 172.16 13.38 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.408 1.083 . . . . 0.0 109.022 170.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 19.9 m -134.96 157.82 45.92 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.986 0.915 . . . . 0.0 109.779 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 73.6 p -134.12 134.73 42.58 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.662 1.185 . . . . 0.0 109.271 -172.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -78.45 78.29 4.92 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.48 0.712 . . . . 0.0 109.197 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.38 -169.33 45.43 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.276 0.941 . . . . 0.0 111.601 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -51.01 -38.67 59.64 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 124.67 3.58 . . . . 0.0 113.048 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -99.59 32.02 2.97 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.426 1.091 . . . . 0.0 110.853 -177.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.54 -157.24 41.94 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -66.5 94.3 0.27 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.934 0.894 . . . . 0.0 110.781 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.4 m -99.57 131.94 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.2 m -99.44 144.34 28.66 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.226 0.61 . . . . 0.0 111.177 -169.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 58.0 mmm . . . . . 0 C--O 1.249 1.073 0 CA-C-O 116.763 -1.589 . . . . 0.0 110.879 -170.924 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.024 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 54.9 t30 53.67 62.94 2.39 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.352 1.461 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.2 tp -157.59 134.86 6.85 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -79.02 65.93 8.81 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.095 2.53 . . . . 0.0 110.423 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -154.14 166.53 32.78 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.519 1.528 . . . . 0.0 109.176 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 24.9 m -134.73 162.53 32.09 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.392 1.077 . . . . 0.0 109.343 175.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.2 p -137.82 142.58 40.79 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.996 1.318 . . . . 0.0 108.733 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -74.55 95.64 2.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.269 0.628 . . . . 0.0 109.355 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.84 178.04 53.98 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.697 0.665 . . . . 0.0 111.459 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.99 -41.85 9.24 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 124.003 3.135 . . . . 0.0 110.91 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -99.44 54.19 0.96 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.94 0.896 . . . . 0.0 109.018 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.76 -176.49 54.67 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 123.716 0.674 . . . . 0.0 111.723 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -65.54 140.02 58.52 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.459 0.704 . . . . 0.0 111.493 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -128.21 136.56 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 125.356 1.462 . . . . 0.0 107.625 174.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.8 m -110.34 148.48 31.88 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.141 0.976 . . . . 0.0 111.099 -174.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.4 mtm . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.443 1.497 . . . . 0.0 110.445 -177.789 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.036 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -72.88 163.77 27.64 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.543 0.737 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.4 tp -64.72 125.64 89.25 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 171.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.67 88.56 1.03 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.947 2.431 . . . . 0.0 109.449 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.2 mmm-85 -157.41 168.78 26.36 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.49 1.116 . . . . 0.0 109.577 -173.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 23.9 m -135.38 154.06 51.61 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.404 1.081 . . . . 0.0 108.795 173.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t -144.34 147.44 33.46 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.714 0.806 . . . . 0.0 109.945 -173.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -72.44 117.6 14.32 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.08 -167.77 11.12 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.522 1.058 . . . . 0.0 111.2 -176.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -51.04 -40.0 59.63 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.729 3.62 . . . . 0.0 113.739 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 -99.56 34.24 2.28 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.23 1.012 . . . . 0.0 110.697 -175.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.33 -156.79 41.79 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -65.98 97.46 0.36 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.995 0.518 . . . . 0.0 109.646 170.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.51 136.14 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.961 1.304 . . . . 0.0 108.17 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.2 m -99.73 146.38 26.6 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.659 0.784 . . . . 0.0 111.008 -174.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.6 mtt . . . . . 0 C--O 1.251 1.169 0 CA-C-O 117.513 -1.232 . . . . 0.0 110.283 -174.446 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.071 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -157.38 158.44 35.91 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.239 1.016 . . . . 0.0 109.031 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.87 159.35 70.24 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 123.654 0.782 . . . . 0.0 109.915 177.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -54.63 98.11 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.926 3.084 . . . . 0.0 112.826 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 86.8 mmt-85 -129.3 106.48 8.84 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 68.6 m -99.32 138.12 36.86 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.844 0.858 . . . . 0.0 111.173 -169.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.2 p -137.27 132.06 33.21 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.536 1.534 . . . . 0.0 108.536 -175.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.04 79.78 2.89 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.573 0.749 . . . . 0.0 109.504 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.39 -166.74 42.15 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.542 1.067 . . . . 0.0 111.44 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.68 -38.0 54.92 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 124.803 3.669 . . . . 0.0 113.28 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -99.55 28.32 4.71 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.414 1.086 . . . . 0.0 110.965 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.48 -156.27 40.81 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -66.01 90.13 0.13 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.069 0.948 . . . . 0.0 110.635 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 p -99.45 135.21 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.7 m -116.83 137.17 52.39 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.598 0.759 . . . . 0.0 111.365 -169.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 76.1 mtm . . . . . 0 C--O 1.251 1.144 0 C-N-CA 124.688 1.195 . . . . 0.0 110.855 -178.036 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.006 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -65.61 -51.83 56.65 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.714 0.805 . . . . 0.0 109.149 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.3 mt -92.92 152.01 41.16 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.575 1.15 . . . . 0.0 108.184 171.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.48 78.52 3.01 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.466 2.777 . . . . 0.0 110.254 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -157.09 140.81 15.98 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.546 1.139 . . . . 0.0 109.101 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.3 m -140.48 153.47 46.25 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.665 0.786 . . . . 0.0 109.565 173.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.0 p -138.2 142.43 39.99 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.983 1.313 . . . . 0.0 108.918 -176.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -74.46 92.48 2.35 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.608 0.763 . . . . 0.0 109.496 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.34 176.25 54.71 Favored Glycine 0 CA--C 1.533 1.162 0 N-CA-C 111.576 -0.609 . . . . 0.0 111.576 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.89 -43.09 62.72 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.971 3.114 . . . . 0.0 112.209 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -99.46 47.57 0.96 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.576 1.15 . . . . 0.0 109.585 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.69 -172.26 54.88 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -67.08 134.73 52.43 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.062 0.545 . . . . 0.0 111.453 -178.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.5 136.38 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 125.437 1.495 . . . . 0.0 107.878 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.2 m -106.92 139.55 41.15 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.349 1.06 . . . . 0.0 109.114 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 72.8 mtm . . . . . 0 C--O 1.25 1.092 0 CA-C-O 117.68 -1.152 . . . . 0.0 110.74 -169.133 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.045 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -156.89 -132.23 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 pp -68.31 147.94 98.23 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 118.911 0.778 . . . . 0.0 109.914 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -70.27 98.01 0.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.778 2.985 . . . . 0.0 111.068 -174.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -165.6 154.54 11.88 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.637 1.175 . . . . 0.0 108.531 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 45.8 m -126.96 146.96 50.14 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.69 0.796 . . . . 0.0 109.789 173.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.8 p -129.51 123.31 31.16 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.814 1.246 . . . . 0.0 109.205 -176.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -69.64 119.84 14.49 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.19 -169.71 11.77 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.483 1.04 . . . . 0.0 111.072 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.02 -38.46 59.22 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 124.647 3.565 . . . . 0.0 113.488 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.3 m-90 -99.51 35.99 1.86 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.324 1.05 . . . . 0.0 110.74 -176.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.33 -157.89 43.13 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -70.07 113.02 6.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.918 0.487 . . . . 0.0 109.712 171.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.4 t -98.91 112.61 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.3 m -99.61 144.96 28.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.962 0.905 . . . . 0.0 111.131 -173.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 96.5 mmm . . . . . 0 C--O 1.252 1.191 0 C-N-CA 126.371 1.868 . . . . 0.0 108.888 179.717 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.048 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -63.6 -56.41 16.1 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 123.468 0.707 . . . . 0.0 109.296 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 38.3 tp -84.86 127.76 63.51 Favored Pre-proline 0 N--CA 1.451 -0.41 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 169.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -58.31 84.32 0.05 OUTLIER 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.914 3.076 . . . . 0.0 112.433 173.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 -165.07 137.13 4.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.005 1.322 . . . . 0.0 107.992 -176.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.5 m -139.77 154.24 47.35 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.678 0.791 . . . . 0.0 109.909 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.1 p -134.09 133.7 41.43 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.922 1.289 . . . . 0.0 108.891 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -76.21 79.82 3.01 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.701 0.8 . . . . 0.0 109.476 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.09 -168.44 44.78 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.3 0.952 . . . . 0.0 111.39 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.86 -38.32 57.38 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 124.606 3.537 . . . . 0.0 113.133 177.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -99.6 30.21 3.71 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.465 1.106 . . . . 0.0 110.882 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.55 -157.76 42.54 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -66.33 95.25 0.3 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.01 0.924 . . . . 0.0 110.69 178.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.1 m -99.52 133.4 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.1 m -108.84 143.83 37.51 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.198 0.999 . . . . 0.0 111.032 -170.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.9 ttp . . . . . 0 C--O 1.251 1.153 0 CA-C-O 116.969 -1.491 . . . . 0.0 109.448 -178.177 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.064 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -72.82 171.47 12.61 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.551 0.741 . . . . 0.0 110.327 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.3 mp -114.47 42.69 0.28 Allowed Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -174.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.64 -46.42 27.14 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.137 1.892 . . . . 0.0 110.718 154.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -155.07 179.0 9.56 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.449 1.099 . . . . 0.0 109.463 170.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.6 m -138.3 163.76 30.97 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.654 0.782 . . . . 0.0 109.209 171.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.5 t -144.93 145.74 31.68 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.064 0.945 . . . . 0.0 109.868 -175.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -69.32 125.14 25.78 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.14 -174.15 13.68 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.322 0.963 . . . . 0.0 111.016 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -53.5 -40.93 77.03 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.346 3.364 . . . . 0.0 113.046 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.2 m-90 -99.55 41.72 1.14 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.28 1.032 . . . . 0.0 110.196 -176.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.29 -159.62 45.14 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -70.0 103.98 2.41 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 173.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.7 m -99.58 136.71 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 124.798 1.239 . . . . 0.0 108.18 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.7 m -99.6 144.86 28.2 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.204 0.602 . . . . 0.0 111.206 -171.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 C--O 1.251 1.184 0 CA-C-O 117.368 -1.301 . . . . 0.0 109.387 -172.494 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.025 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -63.9 -53.1 55.69 Favored 'General case' 0 C--N 1.338 0.075 0 C-N-CA 123.745 0.818 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.8 tt -106.07 110.79 64.32 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 125.422 1.489 . . . . 0.0 107.03 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -46.66 114.26 0.87 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 124.068 3.178 . . . . 0.0 112.574 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -156.46 170.22 22.82 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 124.441 1.097 . . . . 0.0 109.496 -172.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 31.3 m -140.26 155.26 46.93 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.523 0.729 . . . . 0.0 109.175 169.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t -149.07 144.1 26.47 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.761 0.824 . . . . 0.0 109.868 -175.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -79.02 79.72 5.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.06 0.944 . . . . 0.0 109.257 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.76 -169.86 44.87 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.113 0.863 . . . . 0.0 111.45 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.13 -38.82 61.14 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 124.625 3.55 . . . . 0.0 113.09 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -99.6 33.34 2.53 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.483 1.113 . . . . 0.0 110.818 -177.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.52 -157.7 42.53 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -66.59 94.44 0.29 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.887 0.875 . . . . 0.0 110.78 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.8 m -99.66 137.74 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 124.851 1.261 . . . . 0.0 108.074 174.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.7 m -104.89 145.23 30.69 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.796 0.838 . . . . 0.0 110.896 -175.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 C--O 1.251 1.166 0 C-N-CA 125.966 1.706 . . . . 0.0 108.303 -173.083 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.025 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -160.74 175.43 12.63 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.485 1.114 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.45 150.55 54.64 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 123.575 0.75 . . . . 0.0 110.358 178.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.28 82.62 1.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.096 2.531 . . . . 0.0 111.708 -171.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -95.92 167.63 11.13 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.772 1.229 . . . . 0.0 108.917 170.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 57.5 m -140.04 141.99 36.23 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 169.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 t -134.81 138.15 43.99 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 123.902 0.881 . . . . 0.0 109.839 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -79.6 80.34 5.99 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.886 0.875 . . . . 0.0 109.339 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.75 -170.12 46.67 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.178 0.894 . . . . 0.0 111.331 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -51.32 -37.85 61.18 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 124.565 3.51 . . . . 0.0 113.073 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.8 m-90 -99.57 34.46 2.22 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.485 1.114 . . . . 0.0 110.784 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.37 -156.48 41.29 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -67.94 101.11 1.05 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.561 0.745 . . . . 0.0 110.471 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 73.9 t -99.07 119.34 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 176.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 71.6 m -99.79 143.13 30.38 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.083 0.953 . . . . 0.0 110.196 -178.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 24.6 ptp . . . . . 0 C--O 1.25 1.125 0 CA-C-O 117.148 -1.406 . . . . 0.0 110.49 -173.724 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.029 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 -61.64 -46.75 88.45 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.895 0.878 . . . . 0.0 111.049 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.0 mt -129.08 86.55 56.79 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 125.243 1.417 . . . . 0.0 108.089 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -52.67 107.01 0.16 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 124.434 3.423 . . . . 0.0 112.685 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -159.63 144.45 15.26 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.414 1.085 . . . . 0.0 108.089 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 93.6 m -99.87 146.04 27.08 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.563 1.145 . . . . 0.0 110.697 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.1 t -145.73 144.38 30.32 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.63 1.172 . . . . 0.0 109.57 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -76.82 110.83 11.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.86 -173.63 14.83 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.759 1.171 . . . . 0.0 111.189 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -53.02 -40.78 75.39 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.267 3.311 . . . . 0.0 112.996 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.3 m-90 -99.63 42.53 1.1 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.276 1.031 . . . . 0.0 110.372 -176.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.33 -159.82 45.26 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -70.48 99.71 1.66 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.119 0.568 . . . . 0.0 109.902 173.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.3 m -99.55 146.97 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 124.855 1.262 . . . . 0.0 107.873 175.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.1 m -132.46 149.48 52.33 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 122.834 0.453 . . . . 0.0 110.99 -172.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.6 mmt . . . . . 0 C--O 1.25 1.125 0 CA-C-O 117.285 -1.341 . . . . 0.0 109.641 178.401 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.021 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -65.86 -46.18 79.4 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 123.526 0.731 . . . . 0.0 110.346 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 pp -64.21 150.66 92.12 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.102 0.961 . . . . 0.0 109.753 174.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.24 74.07 4.24 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.734 2.956 . . . . 0.0 111.378 -175.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -75.19 104.68 5.86 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 172.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 72.9 m -99.12 140.13 33.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.331 0.653 . . . . 0.0 110.652 -173.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 75.7 p -137.2 142.62 42.12 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.656 1.582 . . . . 0.0 108.363 -176.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -78.23 94.11 4.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.78 177.19 54.41 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.638 0.637 . . . . 0.0 111.542 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.3 -40.81 10.29 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.963 3.109 . . . . 0.0 110.975 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -99.41 53.74 0.95 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.924 0.89 . . . . 0.0 109.074 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.73 -175.89 54.86 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 123.693 0.663 . . . . 0.0 111.642 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 68.7 m95 -66.27 141.6 57.96 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.257 0.623 . . . . 0.0 111.261 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.9 p -139.26 138.94 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 125.448 1.499 . . . . 0.0 107.755 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.5 m -123.41 144.63 49.36 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.633 0.773 . . . . 0.0 110.936 -174.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 C--O 1.251 1.145 0 CA-C-O 117.082 -1.437 . . . . 0.0 110.184 179.624 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.021 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -67.44 -52.58 37.9 Favored 'General case' 0 CA--C 1.526 0.053 0 C-N-CA 123.9 0.88 . . . . 0.0 108.808 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.9 tt -143.13 97.98 5.64 Favored Pre-proline 0 N--CA 1.451 -0.391 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 171.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -40.51 102.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.571 1 C-N-CA 125.393 4.062 . . . . 0.0 114.583 -173.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 33.0 ptt-85 -157.51 160.38 38.17 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.701 1.6 . . . . 0.0 107.998 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 27.3 m -140.13 151.55 45.39 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 122.741 0.416 . . . . 0.0 110.422 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -139.75 146.45 39.55 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.994 0.918 . . . . 0.0 109.873 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -78.7 79.08 5.13 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.133 0.973 . . . . 0.0 109.341 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.95 -165.7 41.51 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.498 1.047 . . . . 0.0 111.532 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -50.25 -39.01 52.81 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 124.956 3.771 . . . . 0.0 113.526 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -99.56 29.89 3.85 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.332 1.053 . . . . 0.0 110.88 -175.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.42 -154.93 39.1 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -65.2 92.25 0.11 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.819 0.848 . . . . 0.0 110.4 175.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.1 p -99.47 135.09 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 125.184 1.393 . . . . 0.0 107.589 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 77.2 m -112.5 149.28 32.88 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.146 0.978 . . . . 0.0 111.703 -169.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.164 0 CA-C-O 116.865 -1.54 . . . . 0.0 111.1 -177.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.014 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.3 t30 69.61 -73.18 0.09 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 126.528 1.931 . . . . 0.0 111.724 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 pp -74.54 164.17 63.17 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 124.225 1.01 . . . . 0.0 109.413 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -45.33 93.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.717 1 C-N-CA 125.456 4.104 . . . . 0.0 114.946 -174.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -149.99 162.07 41.08 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 126.249 1.82 . . . . 0.0 108.232 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 70.9 m -140.06 140.16 36.07 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.733 0.813 . . . . 0.0 109.465 171.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.1 p -128.87 121.94 29.29 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.813 1.245 . . . . 0.0 108.984 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -68.91 121.22 16.14 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.22 -168.87 11.49 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.796 1.189 . . . . 0.0 110.624 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.39 -38.78 63.78 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.506 3.471 . . . . 0.0 113.394 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -99.6 38.03 1.5 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.342 1.057 . . . . 0.0 110.84 -175.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.29 -156.1 40.95 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -69.04 113.53 6.5 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 170.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.0 t -98.84 108.78 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.2 m -99.79 143.43 30.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.967 0.907 . . . . 0.0 111.116 -173.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 93.6 mmm . . . . . 0 C--O 1.251 1.14 0 C-N-CA 125.834 1.654 . . . . 0.0 108.637 -178.563 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 69.8 ttt-85 . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 58.4 m -126.62 153.37 45.42 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.711 0.804 . . . . 0.0 110.424 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.5 p -139.52 143.79 37.6 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.256 1.423 . . . . 0.0 108.932 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.81 109.48 2.49 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -104.02 179.03 24.95 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.223 0.916 . . . . 0.0 111.106 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.81 -44.28 46.48 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.865 3.043 . . . . 0.0 112.023 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -99.47 48.38 0.95 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.53 1.132 . . . . 0.0 109.564 -176.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.53 -168.4 52.72 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -67.67 118.54 11.08 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.792 0.437 . . . . 0.0 110.652 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.3 m -99.73 147.62 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.5 m -128.98 144.45 51.19 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.694 0.798 . . . . 0.0 111.153 -173.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 C--O 1.251 1.172 0 C-N-CA 125.206 1.402 . . . . 0.0 109.479 177.333 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 . . . . . 0 CA--C 1.527 0.086 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.9 m -140.03 159.68 41.64 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 123.729 0.812 . . . . 0.0 109.619 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.5 p -134.41 142.08 47.03 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.78 1.232 . . . . 0.0 109.024 -175.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -71.15 108.58 4.73 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -108.01 -179.06 22.08 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.413 1.006 . . . . 0.0 111.274 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.25 -43.42 56.23 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 124.056 3.17 . . . . 0.0 112.278 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.4 m-90 -99.44 47.05 0.96 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.451 1.1 . . . . 0.0 109.733 -175.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.44 -163.48 48.53 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -69.26 114.18 7.28 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.77 0.428 . . . . 0.0 110.407 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.1 m -99.59 127.49 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.0 m -99.87 152.23 20.39 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.404 0.681 . . . . 0.0 111.844 -170.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 C--O 1.249 1.063 0 C-N-CA 126.16 1.784 . . . . 0.0 109.306 -176.403 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 . . . . . 0 CA--C 1.529 0.137 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 39.0 m -140.2 156.17 46.62 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 170.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -149.11 150.79 33.3 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.134 0.974 . . . . 0.0 109.712 -177.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -66.68 110.3 3.17 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.55 176.75 24.38 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.41 -43.37 58.98 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.814 3.009 . . . . 0.0 111.983 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -99.51 47.82 0.95 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.618 1.167 . . . . 0.0 109.718 -176.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.74 -170.86 54.36 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 49.6 m95 -65.76 112.46 3.73 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.116 0.566 . . . . 0.0 110.808 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.8 p -100.16 137.59 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.828 1.251 . . . . 0.0 108.382 176.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.0 m -105.23 150.79 24.81 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.823 0.849 . . . . 0.0 110.112 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 20.5 ptt? . . . . . 0 C--O 1.251 1.155 0 C-N-CA 125.531 1.533 . . . . 0.0 110.709 -169.509 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.3 m -139.53 163.15 33.31 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.638 0.775 . . . . 0.0 110.219 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.4 t -148.1 152.99 38.27 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.151 0.98 . . . . 0.0 109.619 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -76.88 94.02 3.84 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.658 0.783 . . . . 0.0 108.894 176.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.94 176.04 54.79 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.94 -43.24 61.29 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.993 3.128 . . . . 0.0 112.193 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -99.46 47.06 0.96 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.579 1.152 . . . . 0.0 109.565 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.78 -172.38 54.87 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -64.86 139.24 58.74 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.953 0.501 . . . . 0.0 111.843 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.1 p -139.29 141.05 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 125.377 1.471 . . . . 0.0 108.038 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.8 m -111.79 145.75 38.85 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.421 1.088 . . . . 0.0 110.26 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 28.5 ttt . . . . . 0 C--O 1.25 1.109 0 CA-C-O 117.678 -1.154 . . . . 0.0 110.502 -177.397 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? . . . . . 0 CA--C 1.529 0.137 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -140.36 161.56 37.4 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 123.683 0.793 . . . . 0.0 109.985 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.5 t -147.88 152.21 37.2 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.448 1.099 . . . . 0.0 109.18 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -69.43 108.42 3.74 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 176.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.28 175.76 29.76 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.34 -44.52 45.45 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.766 2.978 . . . . 0.0 111.836 176.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.7 m-90 -99.59 49.6 0.93 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.551 1.14 . . . . 0.0 109.552 -176.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.8 -171.6 54.61 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -65.67 116.03 6.46 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.205 0.602 . . . . 0.0 110.999 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.1 p -99.94 138.98 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 124.849 1.26 . . . . 0.0 108.115 175.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.9 m -115.08 145.35 42.42 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.0 0.92 . . . . 0.0 110.513 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 C--O 1.251 1.142 0 CA-C-O 117.308 -1.33 . . . . 0.0 109.33 -178.736 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 81.6 m -140.03 149.09 42.76 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 123.53 0.732 . . . . 0.0 109.964 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.3 t -150.08 150.63 31.99 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.259 1.024 . . . . 0.0 109.704 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -69.43 109.31 4.14 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -101.86 178.78 27.35 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.031 0.824 . . . . 0.0 111.055 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -56.89 -44.32 45.93 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.863 3.042 . . . . 0.0 111.957 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.4 m-90 -99.46 49.09 0.94 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.545 1.138 . . . . 0.0 109.573 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.57 -168.17 52.46 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -176.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 56.0 m95 -67.76 116.2 8.18 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.934 0.493 . . . . 0.0 110.73 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.8 m -99.95 156.17 4.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 124.702 1.201 . . . . 0.0 108.138 173.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.1 m -136.23 145.71 45.95 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.099 0.56 . . . . 0.0 110.983 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 94.2 mmm . . . . . 0 C--O 1.251 1.167 0 C-N-CA 126.405 1.882 . . . . 0.0 109.946 -178.75 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.5 mtm-85 . . . . . 0 C--O 1.232 0.142 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 19.9 m -134.96 157.82 45.92 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.986 0.915 . . . . 0.0 109.779 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 73.6 p -134.12 134.73 42.58 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.662 1.185 . . . . 0.0 109.271 -172.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -78.45 78.29 4.92 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.48 0.712 . . . . 0.0 109.197 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.38 -169.33 45.43 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.276 0.941 . . . . 0.0 111.601 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -51.01 -38.67 59.64 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 124.67 3.58 . . . . 0.0 113.048 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -99.59 32.02 2.97 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.426 1.091 . . . . 0.0 110.853 -177.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.54 -157.24 41.94 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -66.5 94.3 0.27 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.934 0.894 . . . . 0.0 110.781 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.4 m -99.57 131.94 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.2 m -99.44 144.34 28.66 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.226 0.61 . . . . 0.0 111.177 -169.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 58.0 mmm . . . . . 0 C--O 1.249 1.073 0 CA-C-O 116.763 -1.589 . . . . 0.0 110.879 -170.924 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 24.9 m -134.73 162.53 32.09 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.392 1.077 . . . . 0.0 109.343 175.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.2 p -137.82 142.58 40.79 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.996 1.318 . . . . 0.0 108.733 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -74.55 95.64 2.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.269 0.628 . . . . 0.0 109.355 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.84 178.04 53.98 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.697 0.665 . . . . 0.0 111.459 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.99 -41.85 9.24 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 124.003 3.135 . . . . 0.0 110.91 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -99.44 54.19 0.96 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.94 0.896 . . . . 0.0 109.018 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.76 -176.49 54.67 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 123.716 0.674 . . . . 0.0 111.723 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -65.54 140.02 58.52 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.459 0.704 . . . . 0.0 111.493 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -128.21 136.56 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 125.356 1.462 . . . . 0.0 107.625 174.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.8 m -110.34 148.48 31.88 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.141 0.976 . . . . 0.0 111.099 -174.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.4 mtm . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.443 1.497 . . . . 0.0 110.445 -177.789 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.2 mmm-85 . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 23.9 m -135.38 154.06 51.61 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.404 1.081 . . . . 0.0 108.795 173.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t -144.34 147.44 33.46 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.714 0.806 . . . . 0.0 109.945 -173.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -72.44 117.6 14.32 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.08 -167.77 11.12 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.522 1.058 . . . . 0.0 111.2 -176.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -51.04 -40.0 59.63 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.729 3.62 . . . . 0.0 113.739 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 -99.56 34.24 2.28 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.23 1.012 . . . . 0.0 110.697 -175.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.33 -156.79 41.79 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -65.98 97.46 0.36 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.995 0.518 . . . . 0.0 109.646 170.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.51 136.14 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.961 1.304 . . . . 0.0 108.17 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.2 m -99.73 146.38 26.6 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.659 0.784 . . . . 0.0 111.008 -174.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.6 mtt . . . . . 0 C--O 1.251 1.169 0 CA-C-O 117.513 -1.232 . . . . 0.0 110.283 -174.446 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 86.8 mmt-85 . . . . . 0 N--CA 1.456 -0.153 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 68.6 m -99.32 138.12 36.86 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.844 0.858 . . . . 0.0 111.173 -169.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.2 p -137.27 132.06 33.21 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.536 1.534 . . . . 0.0 108.536 -175.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.04 79.78 2.89 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.573 0.749 . . . . 0.0 109.504 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.39 -166.74 42.15 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.542 1.067 . . . . 0.0 111.44 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.68 -38.0 54.92 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 124.803 3.669 . . . . 0.0 113.28 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -99.55 28.32 4.71 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.414 1.086 . . . . 0.0 110.965 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.48 -156.27 40.81 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -66.01 90.13 0.13 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.069 0.948 . . . . 0.0 110.635 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 p -99.45 135.21 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.7 m -116.83 137.17 52.39 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.598 0.759 . . . . 0.0 111.365 -169.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 76.1 mtm . . . . . 0 C--O 1.251 1.144 0 C-N-CA 124.688 1.195 . . . . 0.0 110.855 -178.036 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 . . . . . 0 C--O 1.233 0.226 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.3 m -140.48 153.47 46.25 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.665 0.786 . . . . 0.0 109.565 173.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.0 p -138.2 142.43 39.99 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.983 1.313 . . . . 0.0 108.918 -176.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -74.46 92.48 2.35 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.608 0.763 . . . . 0.0 109.496 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.34 176.25 54.71 Favored Glycine 0 CA--C 1.533 1.162 0 N-CA-C 111.576 -0.609 . . . . 0.0 111.576 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.89 -43.09 62.72 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.971 3.114 . . . . 0.0 112.209 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -99.46 47.57 0.96 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.576 1.15 . . . . 0.0 109.585 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.69 -172.26 54.88 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -67.08 134.73 52.43 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.062 0.545 . . . . 0.0 111.453 -178.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.5 136.38 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 125.437 1.495 . . . . 0.0 107.878 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.2 m -106.92 139.55 41.15 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.349 1.06 . . . . 0.0 109.114 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 72.8 mtm . . . . . 0 C--O 1.25 1.092 0 CA-C-O 117.68 -1.152 . . . . 0.0 110.74 -169.133 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 . . . . . 0 CA--C 1.528 0.125 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 45.8 m -126.96 146.96 50.14 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.69 0.796 . . . . 0.0 109.789 173.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.8 p -129.51 123.31 31.16 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.814 1.246 . . . . 0.0 109.205 -176.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -69.64 119.84 14.49 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.19 -169.71 11.77 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.483 1.04 . . . . 0.0 111.072 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.02 -38.46 59.22 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 124.647 3.565 . . . . 0.0 113.488 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.3 m-90 -99.51 35.99 1.86 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.324 1.05 . . . . 0.0 110.74 -176.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.33 -157.89 43.13 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -70.07 113.02 6.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.918 0.487 . . . . 0.0 109.712 171.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.4 t -98.91 112.61 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.3 m -99.61 144.96 28.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.962 0.905 . . . . 0.0 111.131 -173.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 96.5 mmm . . . . . 0 C--O 1.252 1.191 0 C-N-CA 126.371 1.868 . . . . 0.0 108.888 179.717 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.5 m -139.77 154.24 47.35 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.678 0.791 . . . . 0.0 109.909 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.1 p -134.09 133.7 41.43 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.922 1.289 . . . . 0.0 108.891 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -76.21 79.82 3.01 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.701 0.8 . . . . 0.0 109.476 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.09 -168.44 44.78 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.3 0.952 . . . . 0.0 111.39 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.86 -38.32 57.38 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 124.606 3.537 . . . . 0.0 113.133 177.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -99.6 30.21 3.71 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.465 1.106 . . . . 0.0 110.882 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.55 -157.76 42.54 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -66.33 95.25 0.3 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.01 0.924 . . . . 0.0 110.69 178.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.1 m -99.52 133.4 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.1 m -108.84 143.83 37.51 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.198 0.999 . . . . 0.0 111.032 -170.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.9 ttp . . . . . 0 C--O 1.251 1.153 0 CA-C-O 116.969 -1.491 . . . . 0.0 109.448 -178.177 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.6 m -138.3 163.76 30.97 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.654 0.782 . . . . 0.0 109.209 171.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.5 t -144.93 145.74 31.68 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.064 0.945 . . . . 0.0 109.868 -175.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -69.32 125.14 25.78 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.14 -174.15 13.68 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.322 0.963 . . . . 0.0 111.016 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -53.5 -40.93 77.03 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.346 3.364 . . . . 0.0 113.046 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.2 m-90 -99.55 41.72 1.14 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.28 1.032 . . . . 0.0 110.196 -176.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.29 -159.62 45.14 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -70.0 103.98 2.41 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 173.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.7 m -99.58 136.71 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 124.798 1.239 . . . . 0.0 108.18 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.7 m -99.6 144.86 28.2 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.204 0.602 . . . . 0.0 111.206 -171.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 C--O 1.251 1.184 0 CA-C-O 117.368 -1.301 . . . . 0.0 109.387 -172.494 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 . . . . . 0 N--CA 1.457 -0.104 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 31.3 m -140.26 155.26 46.93 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.523 0.729 . . . . 0.0 109.175 169.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t -149.07 144.1 26.47 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.761 0.824 . . . . 0.0 109.868 -175.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -79.02 79.72 5.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.06 0.944 . . . . 0.0 109.257 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.76 -169.86 44.87 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.113 0.863 . . . . 0.0 111.45 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.13 -38.82 61.14 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 124.625 3.55 . . . . 0.0 113.09 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -99.6 33.34 2.53 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.483 1.113 . . . . 0.0 110.818 -177.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.52 -157.7 42.53 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -66.59 94.44 0.29 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.887 0.875 . . . . 0.0 110.78 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.8 m -99.66 137.74 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 124.851 1.261 . . . . 0.0 108.074 174.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.7 m -104.89 145.23 30.69 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.796 0.838 . . . . 0.0 110.896 -175.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 C--O 1.251 1.166 0 C-N-CA 125.966 1.706 . . . . 0.0 108.303 -173.083 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 57.5 m -140.04 141.99 36.23 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 169.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 t -134.81 138.15 43.99 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 123.902 0.881 . . . . 0.0 109.839 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -79.6 80.34 5.99 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.886 0.875 . . . . 0.0 109.339 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.75 -170.12 46.67 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.178 0.894 . . . . 0.0 111.331 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -51.32 -37.85 61.18 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 124.565 3.51 . . . . 0.0 113.073 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.8 m-90 -99.57 34.46 2.22 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.485 1.114 . . . . 0.0 110.784 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.37 -156.48 41.29 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -67.94 101.11 1.05 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.561 0.745 . . . . 0.0 110.471 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 73.9 t -99.07 119.34 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 176.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 71.6 m -99.79 143.13 30.38 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.083 0.953 . . . . 0.0 110.196 -178.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 24.6 ptp . . . . . 0 C--O 1.25 1.125 0 CA-C-O 117.148 -1.406 . . . . 0.0 110.49 -173.724 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? . . . . . 0 N--CA 1.453 -0.322 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 93.6 m -99.87 146.04 27.08 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.563 1.145 . . . . 0.0 110.697 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.1 t -145.73 144.38 30.32 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.63 1.172 . . . . 0.0 109.57 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -76.82 110.83 11.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.86 -173.63 14.83 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.759 1.171 . . . . 0.0 111.189 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -53.02 -40.78 75.39 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.267 3.311 . . . . 0.0 112.996 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.3 m-90 -99.63 42.53 1.1 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.276 1.031 . . . . 0.0 110.372 -176.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.33 -159.82 45.26 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -70.48 99.71 1.66 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.119 0.568 . . . . 0.0 109.902 173.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.3 m -99.55 146.97 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 124.855 1.262 . . . . 0.0 107.873 175.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.1 m -132.46 149.48 52.33 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 122.834 0.453 . . . . 0.0 110.99 -172.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.6 mmt . . . . . 0 C--O 1.25 1.125 0 CA-C-O 117.285 -1.341 . . . . 0.0 109.641 178.401 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 72.9 m -99.12 140.13 33.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.331 0.653 . . . . 0.0 110.652 -173.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 75.7 p -137.2 142.62 42.12 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.656 1.582 . . . . 0.0 108.363 -176.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -78.23 94.11 4.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.78 177.19 54.41 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.638 0.637 . . . . 0.0 111.542 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.3 -40.81 10.29 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.963 3.109 . . . . 0.0 110.975 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -99.41 53.74 0.95 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.924 0.89 . . . . 0.0 109.074 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.73 -175.89 54.86 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 123.693 0.663 . . . . 0.0 111.642 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 68.7 m95 -66.27 141.6 57.96 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.257 0.623 . . . . 0.0 111.261 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.9 p -139.26 138.94 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 125.448 1.499 . . . . 0.0 107.755 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.5 m -123.41 144.63 49.36 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.633 0.773 . . . . 0.0 110.936 -174.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 C--O 1.251 1.145 0 CA-C-O 117.082 -1.437 . . . . 0.0 110.184 179.624 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 33.0 ptt-85 . . . . . 0 N--CA 1.454 -0.237 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 27.3 m -140.13 151.55 45.39 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 122.741 0.416 . . . . 0.0 110.422 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -139.75 146.45 39.55 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.994 0.918 . . . . 0.0 109.873 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -78.7 79.08 5.13 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.133 0.973 . . . . 0.0 109.341 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.95 -165.7 41.51 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.498 1.047 . . . . 0.0 111.532 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -50.25 -39.01 52.81 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 124.956 3.771 . . . . 0.0 113.526 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -99.56 29.89 3.85 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.332 1.053 . . . . 0.0 110.88 -175.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.42 -154.93 39.1 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -65.2 92.25 0.11 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.819 0.848 . . . . 0.0 110.4 175.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.1 p -99.47 135.09 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 125.184 1.393 . . . . 0.0 107.589 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 77.2 m -112.5 149.28 32.88 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.146 0.978 . . . . 0.0 111.703 -169.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.164 0 CA-C-O 116.865 -1.54 . . . . 0.0 111.1 -177.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 . . . . . 0 N--CA 1.457 -0.116 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 70.9 m -140.06 140.16 36.07 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.733 0.813 . . . . 0.0 109.465 171.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.1 p -128.87 121.94 29.29 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.813 1.245 . . . . 0.0 108.984 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -68.91 121.22 16.14 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.22 -168.87 11.49 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.796 1.189 . . . . 0.0 110.624 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.39 -38.78 63.78 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.506 3.471 . . . . 0.0 113.394 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -99.6 38.03 1.5 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.342 1.057 . . . . 0.0 110.84 -175.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.29 -156.1 40.95 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -69.04 113.53 6.5 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 170.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.0 t -98.84 108.78 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.2 m -99.79 143.43 30.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.967 0.907 . . . . 0.0 111.116 -173.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 93.6 mmm . . . . . 0 C--O 1.251 1.14 0 C-N-CA 125.834 1.654 . . . . 0.0 108.637 -178.563 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.069 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 65.5 m-20 -70.04 144.88 52.07 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.213 0.605 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 87.8 mt -69.37 147.99 97.16 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 123.352 0.661 . . . . 0.0 109.458 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.09 122.92 10.55 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.983 2.455 . . . . 0.0 110.063 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 69.8 ttt-85 -179.08 150.33 0.46 Allowed 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -174.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 58.4 m -126.62 153.37 45.42 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.711 0.804 . . . . 0.0 110.424 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.5 p -139.52 143.79 37.6 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 125.256 1.423 . . . . 0.0 108.932 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.81 109.48 2.49 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 175.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -104.02 179.03 24.95 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.223 0.916 . . . . 0.0 111.106 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.81 -44.28 46.48 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.865 3.043 . . . . 0.0 112.023 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -99.47 48.38 0.95 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.53 1.132 . . . . 0.0 109.564 -176.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.53 -168.4 52.72 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -67.67 118.54 11.08 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 122.792 0.437 . . . . 0.0 110.652 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.3 m -99.73 147.62 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 95.5 m -128.98 144.45 51.19 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.694 0.798 . . . . 0.0 111.153 -173.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 C--O 1.251 1.172 0 C-N-CA 125.206 1.402 . . . . 0.0 109.479 177.333 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.004 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -83.53 38.11 0.61 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.279 1.032 . . . . 0.0 112.229 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 87.3 mt -137.8 130.89 16.77 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 124.963 1.305 . . . . 0.0 107.856 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -80.94 61.96 8.4 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.333 2.689 . . . . 0.0 109.666 178.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 -146.16 -170.96 3.61 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 124.875 1.27 . . . . 0.0 109.62 -174.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.9 m -140.03 159.68 41.64 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 123.729 0.812 . . . . 0.0 109.619 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.5 p -134.41 142.08 47.03 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.78 1.232 . . . . 0.0 109.024 -175.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -71.15 108.58 4.73 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -108.01 -179.06 22.08 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.413 1.006 . . . . 0.0 111.274 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.25 -43.42 56.23 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 124.056 3.17 . . . . 0.0 112.278 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.4 m-90 -99.44 47.05 0.96 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.451 1.1 . . . . 0.0 109.733 -175.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.44 -163.48 48.53 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -69.26 114.18 7.28 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.77 0.428 . . . . 0.0 110.407 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.1 m -99.59 127.49 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.0 m -99.87 152.23 20.39 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.404 0.681 . . . . 0.0 111.844 -170.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 C--O 1.249 1.063 0 C-N-CA 126.16 1.784 . . . . 0.0 109.306 -176.403 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.036 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -70.97 147.39 48.72 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.342 0.657 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 88.4 mt -63.15 150.99 87.62 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 124.153 0.981 . . . . 0.0 110.888 -177.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.69 95.83 0.29 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.788 2.992 . . . . 0.0 110.197 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -147.05 169.59 18.92 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 125.693 1.597 . . . . 0.0 108.824 -174.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 39.0 m -140.2 156.17 46.62 Favored 'General case' 0 C--O 1.231 0.088 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 170.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -149.11 150.79 33.3 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.134 0.974 . . . . 0.0 109.712 -177.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -66.68 110.3 3.17 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.55 176.75 24.38 Favored Glycine 0 CA--C 1.531 1.091 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.41 -43.37 58.98 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.814 3.009 . . . . 0.0 111.983 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -99.51 47.82 0.95 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.618 1.167 . . . . 0.0 109.718 -176.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.74 -170.86 54.36 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 110.899 -0.881 . . . . 0.0 110.899 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 49.6 m95 -65.76 112.46 3.73 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.116 0.566 . . . . 0.0 110.808 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.8 p -100.16 137.59 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 C-N-CA 124.828 1.251 . . . . 0.0 108.382 176.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 89.0 m -105.23 150.79 24.81 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.823 0.849 . . . . 0.0 110.112 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 20.5 ptt? . . . . . 0 C--O 1.251 1.155 0 C-N-CA 125.531 1.533 . . . . 0.0 110.709 -169.509 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.011 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.4 t30 59.24 77.59 0.3 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.249 1.419 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.1 tp -154.27 137.36 10.26 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -76.86 69.16 7.02 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.126 2.551 . . . . 0.0 110.902 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -148.16 144.86 28.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 126.108 1.763 . . . . 0.0 107.563 174.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.3 m -139.53 163.15 33.31 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.638 0.775 . . . . 0.0 110.219 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.4 t -148.1 152.99 38.27 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.151 0.98 . . . . 0.0 109.619 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -76.88 94.02 3.84 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.658 0.783 . . . . 0.0 108.894 176.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.94 176.04 54.79 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 111.634 -0.587 . . . . 0.0 111.634 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.94 -43.24 61.29 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.993 3.128 . . . . 0.0 112.193 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.2 m-90 -99.46 47.06 0.96 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.579 1.152 . . . . 0.0 109.565 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.78 -172.38 54.87 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -64.86 139.24 58.74 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 122.953 0.501 . . . . 0.0 111.843 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.1 p -139.29 141.05 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 125.377 1.471 . . . . 0.0 108.038 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.8 m -111.79 145.75 38.85 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.421 1.088 . . . . 0.0 110.26 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 28.5 ttt . . . . . 0 C--O 1.25 1.109 0 CA-C-O 117.678 -1.154 . . . . 0.0 110.502 -177.397 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.06 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -60.92 -37.43 82.29 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.982 0.913 . . . . 0.0 111.514 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 65.4 tp -120.14 87.79 40.09 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 173.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -80.73 67.3 8.68 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.734 2.956 . . . . 0.0 111.718 -167.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -108.01 -164.58 0.97 Allowed 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 125.657 1.583 . . . . 0.0 108.385 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.3 m -140.36 161.56 37.4 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 123.683 0.793 . . . . 0.0 109.985 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.5 t -147.88 152.21 37.2 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.448 1.099 . . . . 0.0 109.18 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -69.43 108.42 3.74 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 176.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -98.28 175.76 29.76 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.34 -44.52 45.45 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.766 2.978 . . . . 0.0 111.836 176.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.7 m-90 -99.59 49.6 0.93 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.551 1.14 . . . . 0.0 109.552 -176.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.8 -171.6 54.61 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -65.67 116.03 6.46 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.205 0.602 . . . . 0.0 110.999 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.1 p -99.94 138.98 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 124.849 1.26 . . . . 0.0 108.115 175.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.9 m -115.08 145.35 42.42 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.0 0.92 . . . . 0.0 110.513 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 C--O 1.251 1.142 0 CA-C-O 117.308 -1.33 . . . . 0.0 109.33 -178.736 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.031 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -157.95 161.68 38.2 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.128 0.971 . . . . 0.0 109.178 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.1 mp -61.06 153.29 67.28 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 124.274 1.029 . . . . 0.0 109.645 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -62.5 108.23 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.091 2.527 . . . . 0.0 108.843 174.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -151.65 148.37 27.86 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.35 1.06 . . . . 0.0 108.729 -164.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 81.6 m -140.03 149.09 42.76 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 123.53 0.732 . . . . 0.0 109.964 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.3 t -150.08 150.63 31.99 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.259 1.024 . . . . 0.0 109.704 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -69.43 109.31 4.14 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -101.86 178.78 27.35 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.031 0.824 . . . . 0.0 111.055 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -56.89 -44.32 45.93 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.863 3.042 . . . . 0.0 111.957 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.4 m-90 -99.46 49.09 0.94 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.545 1.138 . . . . 0.0 109.573 -176.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.57 -168.17 52.46 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -176.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 56.0 m95 -67.76 116.2 8.18 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.934 0.493 . . . . 0.0 110.73 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.8 m -99.95 156.17 4.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 124.702 1.201 . . . . 0.0 108.138 173.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.1 m -136.23 145.71 45.95 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 123.099 0.56 . . . . 0.0 110.983 -177.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 94.2 mmm . . . . . 0 C--O 1.251 1.167 0 C-N-CA 126.405 1.882 . . . . 0.0 109.946 -178.75 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.005 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 43.38 55.2 4.9 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.185 1.794 . . . . 0.0 113.038 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.5 pp -149.26 152.44 35.92 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 123.934 0.894 . . . . 0.0 110.142 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -84.62 64.89 6.63 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.448 2.766 . . . . 0.0 111.711 -172.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.5 mtm-85 -144.65 172.16 13.38 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.408 1.083 . . . . 0.0 109.022 170.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 19.9 m -134.96 157.82 45.92 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.986 0.915 . . . . 0.0 109.779 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 73.6 p -134.12 134.73 42.58 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.662 1.185 . . . . 0.0 109.271 -172.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -78.45 78.29 4.92 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.48 0.712 . . . . 0.0 109.197 178.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.38 -169.33 45.43 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.276 0.941 . . . . 0.0 111.601 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -51.01 -38.67 59.64 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 124.67 3.58 . . . . 0.0 113.048 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -99.59 32.02 2.97 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.426 1.091 . . . . 0.0 110.853 -177.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.54 -157.24 41.94 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -66.5 94.3 0.27 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.934 0.894 . . . . 0.0 110.781 177.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.4 m -99.57 131.94 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 174.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.2 m -99.44 144.34 28.66 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.226 0.61 . . . . 0.0 111.177 -169.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 58.0 mmm . . . . . 0 C--O 1.249 1.073 0 CA-C-O 116.763 -1.589 . . . . 0.0 110.879 -170.924 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.024 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 54.9 t30 53.67 62.94 2.39 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.352 1.461 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 17.2 tp -157.59 134.86 6.85 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -79.02 65.93 8.81 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 123.095 2.53 . . . . 0.0 110.423 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -154.14 166.53 32.78 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.519 1.528 . . . . 0.0 109.176 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 24.9 m -134.73 162.53 32.09 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.392 1.077 . . . . 0.0 109.343 175.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.2 p -137.82 142.58 40.79 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.996 1.318 . . . . 0.0 108.733 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -74.55 95.64 2.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.269 0.628 . . . . 0.0 109.355 178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.84 178.04 53.98 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.697 0.665 . . . . 0.0 111.459 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.99 -41.85 9.24 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 124.003 3.135 . . . . 0.0 110.91 -177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -99.44 54.19 0.96 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.94 0.896 . . . . 0.0 109.018 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.76 -176.49 54.67 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 123.716 0.674 . . . . 0.0 111.723 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -65.54 140.02 58.52 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.459 0.704 . . . . 0.0 111.493 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -128.21 136.56 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 125.356 1.462 . . . . 0.0 107.625 174.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 96.8 m -110.34 148.48 31.88 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.141 0.976 . . . . 0.0 111.099 -174.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.4 mtm . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.443 1.497 . . . . 0.0 110.445 -177.789 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.036 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -72.88 163.77 27.64 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.543 0.737 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.4 tp -64.72 125.64 89.25 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 171.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.67 88.56 1.03 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.947 2.431 . . . . 0.0 109.449 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.2 mmm-85 -157.41 168.78 26.36 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.49 1.116 . . . . 0.0 109.577 -173.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 23.9 m -135.38 154.06 51.61 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.404 1.081 . . . . 0.0 108.795 173.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t -144.34 147.44 33.46 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.714 0.806 . . . . 0.0 109.945 -173.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -72.44 117.6 14.32 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.08 -167.77 11.12 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.522 1.058 . . . . 0.0 111.2 -176.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -51.04 -40.0 59.63 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.729 3.62 . . . . 0.0 113.739 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 -99.56 34.24 2.28 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.23 1.012 . . . . 0.0 110.697 -175.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.33 -156.79 41.79 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -65.98 97.46 0.36 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.995 0.518 . . . . 0.0 109.646 170.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.51 136.14 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.961 1.304 . . . . 0.0 108.17 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.2 m -99.73 146.38 26.6 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.659 0.784 . . . . 0.0 111.008 -174.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.6 mtt . . . . . 0 C--O 1.251 1.169 0 CA-C-O 117.513 -1.232 . . . . 0.0 110.283 -174.446 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.071 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -157.38 158.44 35.91 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.239 1.016 . . . . 0.0 109.031 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.87 159.35 70.24 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 123.654 0.782 . . . . 0.0 109.915 177.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -54.63 98.11 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.926 3.084 . . . . 0.0 112.826 176.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 86.8 mmt-85 -129.3 106.48 8.84 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 68.6 m -99.32 138.12 36.86 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.844 0.858 . . . . 0.0 111.173 -169.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 39.2 p -137.27 132.06 33.21 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.536 1.534 . . . . 0.0 108.536 -175.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.04 79.78 2.89 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.573 0.749 . . . . 0.0 109.504 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.39 -166.74 42.15 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.542 1.067 . . . . 0.0 111.44 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -50.68 -38.0 54.92 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 124.803 3.669 . . . . 0.0 113.28 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -99.55 28.32 4.71 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.414 1.086 . . . . 0.0 110.965 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.48 -156.27 40.81 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -66.01 90.13 0.13 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.069 0.948 . . . . 0.0 110.635 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 p -99.45 135.21 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 175.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.7 m -116.83 137.17 52.39 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.598 0.759 . . . . 0.0 111.365 -169.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 76.1 mtm . . . . . 0 C--O 1.251 1.144 0 C-N-CA 124.688 1.195 . . . . 0.0 110.855 -178.036 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.006 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -65.61 -51.83 56.65 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.714 0.805 . . . . 0.0 109.149 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.3 mt -92.92 152.01 41.16 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.575 1.15 . . . . 0.0 108.184 171.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.48 78.52 3.01 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 123.466 2.777 . . . . 0.0 110.254 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -157.09 140.81 15.98 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.546 1.139 . . . . 0.0 109.101 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.3 m -140.48 153.47 46.25 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.665 0.786 . . . . 0.0 109.565 173.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 29.0 p -138.2 142.43 39.99 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.983 1.313 . . . . 0.0 108.918 -176.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -74.46 92.48 2.35 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.608 0.763 . . . . 0.0 109.496 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.34 176.25 54.71 Favored Glycine 0 CA--C 1.533 1.162 0 N-CA-C 111.576 -0.609 . . . . 0.0 111.576 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.89 -43.09 62.72 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.971 3.114 . . . . 0.0 112.209 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -99.46 47.57 0.96 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.576 1.15 . . . . 0.0 109.585 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.69 -172.26 54.88 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -67.08 134.73 52.43 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.062 0.545 . . . . 0.0 111.453 -178.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.5 136.38 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 125.437 1.495 . . . . 0.0 107.878 176.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.2 m -106.92 139.55 41.15 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.349 1.06 . . . . 0.0 109.114 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 72.8 mtm . . . . . 0 C--O 1.25 1.092 0 CA-C-O 117.68 -1.152 . . . . 0.0 110.74 -169.133 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.045 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -156.89 -132.23 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 pp -68.31 147.94 98.23 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 118.911 0.778 . . . . 0.0 109.914 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -70.27 98.01 0.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.778 2.985 . . . . 0.0 111.068 -174.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -165.6 154.54 11.88 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.637 1.175 . . . . 0.0 108.531 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 45.8 m -126.96 146.96 50.14 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.69 0.796 . . . . 0.0 109.789 173.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.8 p -129.51 123.31 31.16 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.814 1.246 . . . . 0.0 109.205 -176.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -69.64 119.84 14.49 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.19 -169.71 11.77 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.483 1.04 . . . . 0.0 111.072 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.02 -38.46 59.22 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 124.647 3.565 . . . . 0.0 113.488 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.3 m-90 -99.51 35.99 1.86 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.324 1.05 . . . . 0.0 110.74 -176.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.33 -157.89 43.13 Favored Glycine 0 C--N 1.339 0.749 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -70.07 113.02 6.87 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 122.918 0.487 . . . . 0.0 109.712 171.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 85.4 t -98.91 112.61 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 98.3 m -99.61 144.96 28.09 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.962 0.905 . . . . 0.0 111.131 -173.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 96.5 mmm . . . . . 0 C--O 1.252 1.191 0 C-N-CA 126.371 1.868 . . . . 0.0 108.888 179.717 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.048 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -63.6 -56.41 16.1 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 123.468 0.707 . . . . 0.0 109.296 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 38.3 tp -84.86 127.76 63.51 Favored Pre-proline 0 N--CA 1.451 -0.41 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 169.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -58.31 84.32 0.05 OUTLIER 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.914 3.076 . . . . 0.0 112.433 173.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 -165.07 137.13 4.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.005 1.322 . . . . 0.0 107.992 -176.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.5 m -139.77 154.24 47.35 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.678 0.791 . . . . 0.0 109.909 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.1 p -134.09 133.7 41.43 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.922 1.289 . . . . 0.0 108.891 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -76.21 79.82 3.01 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.701 0.8 . . . . 0.0 109.476 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.09 -168.44 44.78 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.3 0.952 . . . . 0.0 111.39 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.86 -38.32 57.38 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 124.606 3.537 . . . . 0.0 113.133 177.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -99.6 30.21 3.71 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.465 1.106 . . . . 0.0 110.882 -177.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.55 -157.76 42.54 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -66.33 95.25 0.3 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.01 0.924 . . . . 0.0 110.69 178.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.1 m -99.52 133.4 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.1 m -108.84 143.83 37.51 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.198 0.999 . . . . 0.0 111.032 -170.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.9 ttp . . . . . 0 C--O 1.251 1.153 0 CA-C-O 116.969 -1.491 . . . . 0.0 109.448 -178.177 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.064 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -72.82 171.47 12.61 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.551 0.741 . . . . 0.0 110.327 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.3 mp -114.47 42.69 0.28 Allowed Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -174.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -49.64 -46.42 27.14 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.137 1.892 . . . . 0.0 110.718 154.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -155.07 179.0 9.56 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.449 1.099 . . . . 0.0 109.463 170.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.6 m -138.3 163.76 30.97 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.654 0.782 . . . . 0.0 109.209 171.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.5 t -144.93 145.74 31.68 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.064 0.945 . . . . 0.0 109.868 -175.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -69.32 125.14 25.78 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.14 -174.15 13.68 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.322 0.963 . . . . 0.0 111.016 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -53.5 -40.93 77.03 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.346 3.364 . . . . 0.0 113.046 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.2 m-90 -99.55 41.72 1.14 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.28 1.032 . . . . 0.0 110.196 -176.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.29 -159.62 45.14 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -70.0 103.98 2.41 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 173.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.7 m -99.58 136.71 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 124.798 1.239 . . . . 0.0 108.18 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.7 m -99.6 144.86 28.2 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.204 0.602 . . . . 0.0 111.206 -171.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 C--O 1.251 1.184 0 CA-C-O 117.368 -1.301 . . . . 0.0 109.387 -172.494 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.025 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -63.9 -53.1 55.69 Favored 'General case' 0 C--N 1.338 0.075 0 C-N-CA 123.745 0.818 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.8 tt -106.07 110.79 64.32 Favored Pre-proline 0 CA--C 1.534 0.33 0 C-N-CA 125.422 1.489 . . . . 0.0 107.03 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -46.66 114.26 0.87 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 124.068 3.178 . . . . 0.0 112.574 177.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -156.46 170.22 22.82 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 124.441 1.097 . . . . 0.0 109.496 -172.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 31.3 m -140.26 155.26 46.93 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.523 0.729 . . . . 0.0 109.175 169.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t -149.07 144.1 26.47 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.761 0.824 . . . . 0.0 109.868 -175.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -79.02 79.72 5.4 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.06 0.944 . . . . 0.0 109.257 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.76 -169.86 44.87 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 124.113 0.863 . . . . 0.0 111.45 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.13 -38.82 61.14 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 124.625 3.55 . . . . 0.0 113.09 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -99.6 33.34 2.53 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.483 1.113 . . . . 0.0 110.818 -177.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.52 -157.7 42.53 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -66.59 94.44 0.29 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.887 0.875 . . . . 0.0 110.78 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.8 m -99.66 137.74 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 C-N-CA 124.851 1.261 . . . . 0.0 108.074 174.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.7 m -104.89 145.23 30.69 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.796 0.838 . . . . 0.0 110.896 -175.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 C--O 1.251 1.166 0 C-N-CA 125.966 1.706 . . . . 0.0 108.303 -173.083 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.025 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -160.74 175.43 12.63 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.485 1.114 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.45 150.55 54.64 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 123.575 0.75 . . . . 0.0 110.358 178.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.28 82.62 1.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.096 2.531 . . . . 0.0 111.708 -171.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -95.92 167.63 11.13 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 124.772 1.229 . . . . 0.0 108.917 170.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 57.5 m -140.04 141.99 36.23 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 169.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.8 t -134.81 138.15 43.99 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 123.902 0.881 . . . . 0.0 109.839 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -79.6 80.34 5.99 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.886 0.875 . . . . 0.0 109.339 -178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.75 -170.12 46.67 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.178 0.894 . . . . 0.0 111.331 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -51.32 -37.85 61.18 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 124.565 3.51 . . . . 0.0 113.073 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.8 m-90 -99.57 34.46 2.22 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.485 1.114 . . . . 0.0 110.784 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.37 -156.48 41.29 Favored Glycine 0 C--N 1.34 0.804 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -67.94 101.11 1.05 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.561 0.745 . . . . 0.0 110.471 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 73.9 t -99.07 119.34 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 176.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 71.6 m -99.79 143.13 30.38 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.083 0.953 . . . . 0.0 110.196 -178.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 24.6 ptp . . . . . 0 C--O 1.25 1.125 0 CA-C-O 117.148 -1.406 . . . . 0.0 110.49 -173.724 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.029 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 -61.64 -46.75 88.45 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.895 0.878 . . . . 0.0 111.049 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.0 mt -129.08 86.55 56.79 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 125.243 1.417 . . . . 0.0 108.089 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -52.67 107.01 0.16 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 124.434 3.423 . . . . 0.0 112.685 -179.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.5 tpm_? -159.63 144.45 15.26 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.414 1.085 . . . . 0.0 108.089 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 93.6 m -99.87 146.04 27.08 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.563 1.145 . . . . 0.0 110.697 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.1 t -145.73 144.38 30.32 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.63 1.172 . . . . 0.0 109.57 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -76.82 110.83 11.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.86 -173.63 14.83 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.759 1.171 . . . . 0.0 111.189 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -53.02 -40.78 75.39 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.267 3.311 . . . . 0.0 112.996 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.3 m-90 -99.63 42.53 1.1 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.276 1.031 . . . . 0.0 110.372 -176.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.33 -159.82 45.26 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -70.48 99.71 1.66 Allowed 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.119 0.568 . . . . 0.0 109.902 173.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.3 m -99.55 146.97 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 124.855 1.262 . . . . 0.0 107.873 175.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.1 m -132.46 149.48 52.33 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 122.834 0.453 . . . . 0.0 110.99 -172.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.6 mmt . . . . . 0 C--O 1.25 1.125 0 CA-C-O 117.285 -1.341 . . . . 0.0 109.641 178.401 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.021 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -65.86 -46.18 79.4 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 123.526 0.731 . . . . 0.0 110.346 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 pp -64.21 150.66 92.12 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.102 0.961 . . . . 0.0 109.753 174.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.24 74.07 4.24 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.734 2.956 . . . . 0.0 111.378 -175.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -75.19 104.68 5.86 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 172.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 72.9 m -99.12 140.13 33.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.331 0.653 . . . . 0.0 110.652 -173.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 75.7 p -137.2 142.62 42.12 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.656 1.582 . . . . 0.0 108.363 -176.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -78.23 94.11 4.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.78 177.19 54.41 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.638 0.637 . . . . 0.0 111.542 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.3 -40.81 10.29 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.963 3.109 . . . . 0.0 110.975 -177.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -99.41 53.74 0.95 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.924 0.89 . . . . 0.0 109.074 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.73 -175.89 54.86 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 123.693 0.663 . . . . 0.0 111.642 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 68.7 m95 -66.27 141.6 57.96 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.257 0.623 . . . . 0.0 111.261 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.9 p -139.26 138.94 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 125.448 1.499 . . . . 0.0 107.755 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.5 m -123.41 144.63 49.36 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.633 0.773 . . . . 0.0 110.936 -174.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 C--O 1.251 1.145 0 CA-C-O 117.082 -1.437 . . . . 0.0 110.184 179.624 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.021 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -67.44 -52.58 37.9 Favored 'General case' 0 CA--C 1.526 0.053 0 C-N-CA 123.9 0.88 . . . . 0.0 108.808 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.9 tt -143.13 97.98 5.64 Favored Pre-proline 0 N--CA 1.451 -0.391 0 N-CA-C 104.334 -2.469 . . . . 0.0 104.334 171.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -40.51 102.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.571 1 C-N-CA 125.393 4.062 . . . . 0.0 114.583 -173.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 33.0 ptt-85 -157.51 160.38 38.17 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.701 1.6 . . . . 0.0 107.998 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 27.3 m -140.13 151.55 45.39 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 122.741 0.416 . . . . 0.0 110.422 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -139.75 146.45 39.55 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.994 0.918 . . . . 0.0 109.873 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -78.7 79.08 5.13 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.133 0.973 . . . . 0.0 109.341 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -88.95 -165.7 41.51 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.498 1.047 . . . . 0.0 111.532 -179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -50.25 -39.01 52.81 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 124.956 3.771 . . . . 0.0 113.526 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -99.56 29.89 3.85 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.332 1.053 . . . . 0.0 110.88 -175.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.42 -154.93 39.1 Favored Glycine 0 C--N 1.34 0.765 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -65.2 92.25 0.11 Allowed 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.819 0.848 . . . . 0.0 110.4 175.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.1 p -99.47 135.09 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 125.184 1.393 . . . . 0.0 107.589 178.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 77.2 m -112.5 149.28 32.88 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.146 0.978 . . . . 0.0 111.703 -169.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.251 1.164 0 CA-C-O 116.865 -1.54 . . . . 0.0 111.1 -177.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.014 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.3 t30 69.61 -73.18 0.09 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 126.528 1.931 . . . . 0.0 111.724 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.2 pp -74.54 164.17 63.17 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 124.225 1.01 . . . . 0.0 109.413 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -45.33 93.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.717 1 C-N-CA 125.456 4.104 . . . . 0.0 114.946 -174.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -149.99 162.07 41.08 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 126.249 1.82 . . . . 0.0 108.232 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 70.9 m -140.06 140.16 36.07 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.733 0.813 . . . . 0.0 109.465 171.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.1 p -128.87 121.94 29.29 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.813 1.245 . . . . 0.0 108.984 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -68.91 121.22 16.14 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.22 -168.87 11.49 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.796 1.189 . . . . 0.0 110.624 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.39 -38.78 63.78 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 124.506 3.471 . . . . 0.0 113.394 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -99.6 38.03 1.5 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.342 1.057 . . . . 0.0 110.84 -175.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.29 -156.1 40.95 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -69.04 113.53 6.5 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 170.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 95.0 t -98.84 108.78 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.2 m -99.79 143.43 30.03 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.967 0.907 . . . . 0.0 111.116 -173.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 93.6 mmm . . . . . 0 C--O 1.251 1.14 0 C-N-CA 125.834 1.654 . . . . 0.0 108.637 -178.563 . . . . . . . . 0 0 . 1 stop_ save_